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ABSTRACT OF THE DISSERTATION 
Evaluating Racial and Geospatial Disparities and Contextual Factors in Triple-Negative 
Breast Cancer among Women with Breast Cancer 
by 
Lia Cenni Barnar Scott 
The objective of this study is to examine racial and geospatial disparities in triple-negative breast 
cancer diagnosis. Breast cancer, in general, carries an enormous public health burden. Triple-
negative breast cancer has greater morbidity and mortality, presenting approximately 9% of all 
breast cancer diagnoses, in this study. This type of breast cancer has been significantly associated 
with younger age, African American race, later stage diagnosis, lower socioeconomic status and 
worse survival. The proposed study will be the first of its kind to use data from the United States 
Cancer Statistics database which includes combined cancer incidence data from the Centers for 
Disease Control and Prevention’s (CDC) National Program of Cancer Registries (NPCR) and the 
Surveillance, Epidemiology, and End Results (SEER) Program covering 99% of the population 
in comparison to 28% with SEER data alone. This study evaluates individual, social and physical 
environmental factors associated with disparate rates of diagnosis. Predictors of interest include 
person level-predictors (race, age, and stage of diagnosis), county-level predictors (residential 
segregation, social capital and socioeconomic climate), and state-level predictors (breast cancer 
screening mandates, state-level underinsured rates and state-specific restrictions on nurse 
practitioner or physician assistant scope of practice). Descriptive epidemiologic analysis allowed 
us to compare incidence of triple negative breast cancer across race and age groups at the 
individual level. This study confirmed that Non-Hispanic black women consistently had 
approximately twice the odds of diagnosis of triple negative breast cancer given breast cancer 
diagnosis, when compared to Non-Hispanic white women. Younger age and late stage diagnosis 
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also conferred higher odds. Exploratory spatial data analysis was used to create descriptive maps 
and evaluate patterns of geospatial clustering and underlying community characteristics. This 
study found distinct patterns of breast cancer and triple negative breast cancer rates at the county 
level. It found 159 counties where breast cancer rates and triple negative breast cancer rates were 
concurrently high and 97 counties where breast cancer rates were low, but triple negative breast 
cancer rates were high. Spatial regression techniques demonstrated that residential segregation 
was consistently associated with both breast and triple negative breast cancer rates. Isolation was 
found to be detrimental while diversity was advantageous. Multilevel modeling allowed the 
exploration of predictors of triple-negative breast cancer diagnosis at the individual level. 
Consistently, race, age and late stage diagnosis conferred higher odds of diagnosis with triple 
negative breast cancer, given breast cancer diagnosis. Residential segregation measures were 
consistently associated, with isolation conferring higher odds and diversity conferring lower odds 
of diagnosis. The results of these studies potentially inform policy at actionable geographic 
levels and add valuable information to cancer health disparities research. Additionally, they 
provide insight that there is still a need to explore what factors may be driving racial and 
geospatial disparities in triple negative breast cancer in the United States.  
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Epidemiology of Triple-Negative Breast Cancer 
Carcinoma of the breast, or breast cancer, is the most common type of noncutaneous 
cancer among women. It is expected that there will be 63,960 in situ cases, 266,120 invasive 
cases, and 40,920 deaths in women in 2018. The probability of developing invasive breast cancer 
increases with age and is 12.4% or 1 in 8 for a lifetime. (Siegel, Miller, & Jemal, 2018). When 
we examine the five leading causes of cancer death in 2015, among females, breast cancer is the 
second only behind lung and bronchus. However, for age 20 to 59, it is the first leading cause of 
cancer death (Siegel et al., 2018). Approximately 80% of breast cancers are invasive with up to 
21 distinct histological subtypes and at least 4 different molecular subtypes (American Cancer 
Society, 2017). 
Numerous biologic subtypes of breast cancer demonstrate that it is a heterogeneous 
disease (Carey et al., 2006). These subtypes are based on gene expression patterns that include 
496 genes (Perou et al., 2000). There are five intrinsic subtypes recognized. Two estrogen 
receptor (ER)-positive types include luminal A (ER+/progesterone receptor (PR)-positive and 
human epidermal growth factor receptor 2(HER2)-negative) and luminal B (ER+/PR+/HER2+). 
Three ER-negative types include ER-/PR-/HER2+, basal-like (ER-/PR-/HER2-/cytokeratin 5/6 
(CK5/6) +), and unclassified ‘normal-like’ (negative for all markers) (Yang, Pfeiffer, et al., 2007; 
Yang, Sherman, et al., 2007). These subtypes differ markedly in prognosis and therapeutic 
targets (Sorlie et al., 2001).  Luminal A tumors have the most favorable clinical features, 
followed by luminal B (Yang et al., 2007). ER positive tumors respond to endocrine therapy such 
as antiestrogen administration or ovarian suppression. HER2 positivity provides bases for 
targeted therapy with monoclonal antibody against HER2 (Bauer et al., 2007) Basal-like tumors 
have poor clinical features and survival, due to the negative ER and HER2 status. ER and PR 
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negative tumors account for approximately 20% of breast cancers with known receptor status 
and include the most clinically aggressive tumors (Yang et al., 2007). Triple negative breast 
cancer (TNBC) accounts for approximately 12-15% of all breast cancer cases and approximately 
75-90% are deemed basal-like (Dolle et al., 2009; American Cancer Society, 2017). TNBC is 
associated with aggressive histology, poorer prognosis, shorter survival, and unresponsiveness to 
usual hormone and HER2 immunotherapy (Bauer, Brown, Cress, Parise, & Caggiano, 2007). 
This is important to note as basal-like tumors have a characteristic morphology that includes high 
proliferative rate, central necrosis, and a pushing border (when the edge of the tumor appears to 
be pushing into normal tissue) and have been associated with aggressive histology, unresponsive 
to hormone therapy, poor prognosis, and BRCA-1 gene mutation (Dolle et al., 2009; Kreike et al., 
2007; Livasy et al., 2006; Foulkes et al., 2003; Perou et al., 2000; Sorlie et al., 2001; Sorlie et al., 
2003; Foulkes et al., 2010).  
Triple negative breast cancers are more likely than any other breast cancer type to 
metastasize to viscera, specifically the lungs and the brain (Foulkes et al., 2010). There is 
approximately a 40% chance of first distant recurrence in the lungs for metastatic triple negative 
breast cancer, while there is only a 20% chance for non-triple negative breast cancer (Foulkes et 
al., 2010). A study conducted using the California cancer registry found that the triple negative 
phenotype was statistically significantly associated with younger age, Non-Hispanic black 
race/ethnicity, later stage diagnosis, lower SES and shortened survival (Bauer et al., 2007). Non-
Hispanic black women also have statistically significant earlier age at diagnosis, higher 
proportion of high grade tumors, and a higher proportion of triple-negative breast cancers 
suggesting that breast cancer in Non-Hispanic black women is biologically different (Chu, 
Lamar, & Freeman, 2003; Newman, 2005). These disparate outcomes and lack of knowledge of 
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etiology of disease provide reason as to why research must shift focus from treatment to 
identifying risk factors, albeit environmental or genetic, that exacerbate disparities in breast 
cancer diagnosis to develop and implement more efficacious population-based prevention 
strategies. 
Individual Risk Factors  
Race - Disparities between Non-Hispanic black and Non-Hispanic white women 
Racial disparities exist within breast cancer diagnoses, particularly between non-Hispanic 
white and non-Hispanic black populations. Incidence trends from 2005 to 2014 demonstrate that 
invasive breast cancer rates were stable for non-Hispanic white women and increased slightly for 
non-Hispanic black women. Over the 10-year span, invasive breast cancer rates for Non-
Hispanic black women increased approximately 3%. Overall breast cancer mortality rates have 
declined since 1989. Mortality peaked in 1989 at 33.2 deaths per 100,000 and declined 39% to 
20.3 deaths per 100,000 in 2015. This decline has been attributed to early detection and 
screening. The annual percent decline from 2006 to 2015 was larger for non-Hispanic white 
women compared to non-Hispanic black women, 1.8% versus 1.5%, respectively (Siegel et al., 
2018). 
According to SEER data from 18 registries, the lifetime relative risk of all breast cancers 
from 2013-2015 for Non-Hispanic black women compared to Non-Hispanic white women is 
0.90, indicating Non-Hispanic black women are at lower risk for diagnosis, yet the lifetime 
relative risk for dying of breast cancer is 1.22. When Non-Hispanic black women are diagnosed 
with breast cancer, there are 22% more likely to die from the disease. Age-adjusted incidence 
rates from 2011- 2015 were 128.6 per 100,000 for non-Hispanic white women and 126.9 per 
100,000 for non-Hispanic black women. The age-adjusted mortality rates from breast cancer in 
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2011-2015 for Non-Hispanic black women was 28.7 per 100,000 and 20.3 deaths per 100,000 for 
Non-Hispanic white women (Noone et al., 2018). When examining cases from 2008 to 2014, 
Non-Hispanic white women had a higher percentage of localized disease as compared to Non-
Hispanic black women (63% vs 54%), yet the 5-year relative survival rate for Non-Hispanic 
black women was lower in terms of localized (99.1% vs 95.4%), regional (86.4% vs 76.6%), and 
distant stages (28.1% vs.19.7%) (Noone et al., 2018). Survival in Non-Hispanic black women 
may be worse due to a higher frequency of adverse histologic features (Bauer et al., 2007).  
Incidence data are from the 18 registries, while mortality data are for the entire United States. 
Lifetime Exposure to Estrogen 
Besides race, research has established multiple individual risk factors associated with 
breast cancer diagnoses, although the complete etiology of the disease remains unknown. 
Lifetime exposure to estrogen has been linked to increased risk for breast cancer (Loeffler & 
Hart, 2014). These factors include early menarche, late menopause, no or fewer children, and 
receiving exogenous estrogen (Loeffler & Hart, 2014).). In addition, women who had children 
but did not breastfeed are at increased risk compared to those who breastfed (Loeffler & Hart, 
2014). High levels of circulating estrogens and androgens have been associated with increased 
risk of breast cancer in premenopausal women (Key et al., 2013). Parity also plays a role. Having 
a first child before 35 and a greater number of children is associated with decreased risk for 
hormone receptor positive breast cancers (Lambertini et al., 2016). On the contrary, there is an 
increase in hormone receptor negative breast cancer risk that last about 10 years post full-term 
pregnancy, particularly among women who are older at birth (Albrektsen, Heuch, Hansen, & 
Kvåle, 2005; Schedin, 2006). Breastfeeding also slightly reduces overall risk of breast cancer if 
done for at least a year (Faupel-Badger et al., 2012). The risk of breast cancer is reduced by 4% 
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for every 12 months of breastfeeding (Collaborative Group on Hormonal Factors in Breast 
Cancer, 2002). This may be due to the inhibition of menstruation when breastfeeding, thus 
reducing lifetime number of menstrual cycles, or the structural changes that occur in the breast 
following lactation and weaning (Britt, Ashworth, & Smalley, 2007; Faupel-Badger et al., 2012). 
This effect was found to be stronger among triple-negative cases (Faupel-Badger et al., 2012; 
Islami et al., 2015; Sisti et al., 2016). 
Family History 
Women with a family history of breast cancer, especially in a first-degree relative have 
an increased risk of breast cancer diagnosis. When we compare them to women without a family 
history, their risk of diagnosis is twice as high when there is only one affected first degree female 
relative, and almost 4 times as high when there are multiple first-degree female relatives with 
breast cancer (Collaborative Group on Hormonal Factors in Breast Cancer, 2001). Additionally, 
a family history of ovarian cancer is also associated with higher risk of breast cancer diagnosis 
(American Cancer Society, 2017). Women who have been diagnosed with breast cancer have a 
small increased risk of developing a new cancer in the opposite breast (Nichols, De González, 
Lacey Jr, Rosenberg, & Anderson, 2011). Ductal carcinoma in situ (DCIS) and Lobular 
Carcinomas in situ (LCIS) are both potential precursors for invasive breast cancer. Women with 
a history of DCIS are 10 times more likely to be diagnosed with an invasive breast cancer and 
women with LCIS are 7 to 12 times more likely to develop invasive breast cancer compared to 
women with either (King et al., 2015; Lopez‐Garcia, Geyer, Lacroix‐Triki, Marchió, & Reis‐
Filho, 2010; Morrow, Schnitt, & Norton, 2015). 
Genetic Predisposition 
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The most indicative of these risk factors is the mutation of the BRCA genes. BRCA genes 
are tumor suppression genes that repair damaged DNA and prevent cell division in damaged 
cells. A mutation in either BRCA-1 or BRCA-2 increases the risk of breast cancer from 12% up to 
70% (Kuchenbaecker et al., 2017). These mutations occur at a rate of less than 1% in the general 
population but occur slightly more often in certain ethnic or geographically isolated groups 
(Gabai-Kapara et al., 2014).  Another gene that works with BRCA-2, PALB-2, appears to confer 
risk that may be as high as BRCA-2 mutations (Antoniou et al., 2014). Multiple research avenues 
are being explored to determine what oncogenes or tumor suppressor genes play a role in the 
various subtypes of breast cancer (Li et al., 2015; McLean et al., 2015; Plíšková, Vondráček, 
Vojtěšek, Kozubík, & Machala, 2004). There are no known recurring breast cancer gene 
mutations that have an increased frequency in non-Hispanic black women (Chen et al., 1994; 
Cross, Harris, & Recht, 2002; Gao, Neuhausen, Cummings, Luce, & Olopade, 1997; Newman et 
al., 1998; Shen et al., 2000).  Additionally, not much is known about the interaction of genes and 
environmental factors that may be different between non-Hispanic black and non-Hispanic white 
women (Cross et al., 2002). 
Height 
Height has also been associated with increased breast cancer risk (Green et al., 2011; van 
den Brandt et al., 2000). A study found that in a European sample, height was an independent 
risk factor for breast cancer among postmenopausal women, but the relationship was unclear 
among premenopausal women (van den Brandt et al., 2000). Increased height was associated 
with increased risk of cancer and cancer death in another European study (Wirén et al., 2014). 
Height may be reflective of differences in early growth or hormonal factors.  
Obesity 
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Obesity plays a different role in breast cancer risk when we compare pre- and post-
menopausal women. In a meta-analysis study of premenopausal women, breast cancer risk was 
1% lower in overweight women and 26% lower in obese women compared to women of normal 
weight (Nelson et al., 2012). However, this may be limited to hormone receptor positive tumors. 
The postmenopausal risk of breast cancer is 1.5 times higher in overweight women and 2 times 
higher in obese women (La Vecchia, Giordano, Hortobagyi, & Chabner, 2011). Obesity is also a 
risk factor for type II diabetes which is linked to increases risk of postmenopausal breast cancer 
(16% increase) (Boyle et al., 2012; Maskarinec et al., 2017; Tsilidis, Kasimis, Lopez, Ntzani, & 
Ioannidis, 2015). Women who exercise regularly had 10-20% lower risk of breast cancer 
compared to women who are inactive (Pizot et al., 2016). The reduction is greater with 
increasing amounts of exercise and vigorous activity, but even less vigorous physical activity, 
such as walking, is beneficial (Hildebrand, Gapstur, Campbell, Gaudet, & Patel, 2013). This may 
be because of the effect of physical activity on inflammation, hormones, and energy balance 
(Neilson, Friedenreich, Brockton, & Millikan, 2009; Pizot et al., 2016).  
Determination of Social Environmental Risk Factors 
The identification of factors that create and exacerbate these disparities would be an ideal 
outcome of this and future cancer epidemiology studies. Biological risk factors have been 
identified and are consistently validated, yet disparities still exist. Dating back to 1991, 
socioeconomic status (SES) has been studied as a factor in cancer incidence. A study examining 
the association between census tract level income and educational levels as proxies for 
socioeconomic status and cancer incidence at all sites combined found that the disproportionate 
distribution of the non-Hispanic black population at lower socioeconomic levels accounts for 
much of the excess burden among this population (Baquet, Horm, Gibbs, & Greenwald, 1991). 
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SES variables are not collected with patient characteristics in cancer registries. Thus, it is not 
surprising that few studies have explored the role of social environmental risk factors in triple 
negative breast cancer diagnosis, specifically (Chu, Henderson, Ampil, & Li, 2012; Dolle et al., 
2009). Collection of additional social environmental risk factors that vary among women can 
inform both policy and clinical practice. Lacking such person-specific SES data, this study aims 
to illuminate the role that residential segregation, socioeconomic conditions and other contextual 
factors in the counties where women live may play in the diagnosis of TNBC. This study looks at 
the following factors from an ecological standpoint, rather than compositional. 
Residential Segregation  
Residential segregation adversely impacts the health of non-Hispanic black persons 
(Collins, 1999; Collins & Williams, 1999). Segregation promulgates negative social 
environments as highly segregated cities often experience higher levels of violent and property 
crimes (Kramer & Hogue, 2009; Peterson & Krivo, 1993; Velez, Krivo, & Peterson, 2003). 
Residential segregation impacts access to health-relevant sources. Even after controlling for risk 
factors, segregation may have a statistically significant effect on health outcomes because of the 
way it shapes contact patterns and social networks (Acevedo-Garcia, 2000; Acevedo-Garcia, 
Lochner, Osypuk, & Subramanian, 2003).  
There has research conducted using SEER registry data and a sample of 395,671 US-born 
non-Hispanic black and non-Hispanic white women that found that Jim Crow birthplace was 
associated with increased odds of estrogen receptor negative breast cancer among non-Hispanic 
black women with the strongest effect for women born before 1965 (Krieger, Jahn and 
Waterman, 2017). In terms of breast cancer care, Haas and colleagues (2008) found that non-
Hispanic black segregation was a mediator of the Black/White disparity in breast cancer care. 
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They also found that both non-Hispanic black and non-Hispanic white women who lived in areas 
of greater non-Hispanic black segregation were less likely to receive adequate breast cancer care. 
Socioeconomic Status 
Socioeconomic position has been linked to breast cancer incidence. Studies show that this 
construct is positively related to breast cancer incidence overall, but the association varies by 
race or ethnicity (Bigby & Holmes, 2005; Yost, Perkins, Cohen, Morris, & Wright, 2001). 
Research demonstrates that the United States is the most unequal in terms of wealth distribution 
among all developed countries. The top 1 percent of households own 38 to 47 percent of all 
wealth (Keister & Moller, 2000; Wolff, 1996, 1998). The Gini coefficient is the most commonly 
used indicator of income inequality, and its use here allows for comparisons with other income 
inequality studies (Jones-Smith, Gordon-Larsen, Siddiqi, & Popkin, 2011; Nowatzki, 2012). The 
association between income inequality and mortality has also been established at cross-country 
and national levels (Chetty et al., 2016; Kaplan, Pamuk, Lynch, Cohen, & Balfour, 1996; 
McIsaac & Wilkinson, 1997).  
Education is often considered a social determinant of health under the umbrella of 
socioeconomic status. One study found that having low self-reported education was associated 
with subtypes of estrogen receptor negative and progesterone receptor negative breast cancers 
(Trivers et al., 2009). Additionally, women in their study with triple negative tumors were more 
often of lower SES. Low-income women have mammography screening rates that are lower than 
higher income women (Peek & Han, 2004). Additionally, women with lower education have 
lower mammography screening rates (Kerner et al., 2001). Women in low-income areas are more 
likely to present with late stage disease and socioeconomic position has also been association 
with treatment (Schwartz, Crossley-May, Vigneau, Brown, & Banerjee, 2003). 
RACIAL AND GEOSPATIAL DISPARITIES IN TRIPLE NEGATIVE BREAST CANCER 
  13 
Low socioeconomic status has been linked to decreased rates of screening, greater 
probability for late-stage diagnosis, receipt on inadequate and disparate treatment and higher 
mortality from breast cancer (Bigby & Holmes, 2005; Gerend & Pai, 2008). Regardless of race, 
poverty is associated with poorer breast cancer outcomes (Gerend & Pai, 2008). Socioeconomic 
status is often linked to access to care as they often go hand-in-hand. Those with lower 
socioeconomic status are less likely to have employment stability that provides adequate 
insurance for care. Additionally, studies have found that the non-Hispanic black population is 
twice as likely to be uninsured and depend on public insurance compared to the non-Hispanic 
white population (Thomasson, 2006). Uninsured and underinsured women are less likely to 
undergo screening, more likely to receive a late stage diagnosis and less likely to survive 
(Bradley, Given, & Roberts, 2002; Buseman, Byers, Finch, & Jacobellis, 2002; Gerend & Pai, 
2008; Gordon, Rundall, & Parker, 1998; Hsia et al., 2000; Roetzheim et al., 1999). Women who 
reside in disadvantaged communities may be required to travel longer distances with longer wait 
times to utilize screening and treatment facilities. These factors can cause a major hindrance in 
regular physician visits (Mandelblatt, Andrews, Kao, Wallace, & Kerner, 2010; Mandelblatt, 
Andrews, Kerner, Zauber, & Burnett, 1991; Mandelblatt, Yabroff, & Kerner, 1999; Vernon, 
Vogel, Halabi, & Bondy, 1993). 
Higher socioeconomic status confers a higher risk of breast cancer diagnosis, while lower 
socioeconomic status confers higher risk of triple negative breast cancer diagnosis. In terms of 
triple negative diagnosis, this type occurs more frequently in younger women and in non-
Hispanic black women (Bauer et al., 2007; Dent et al., 2007; Haffty et al., 2006; Harris et al., 
2006; Morris et al., 2007; Tischkowitz et al., 2007). Socioeconomic status has been examined as 
a factor in breast cancer incidence and the National Action Plan on Breast Cancer Workshop 
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recommended that it be an integral part of research in breast cancer etiology, since this variable 
is associated with many other factors in an individual’s life (Dayal, Power, & Chiu, 1982; 
Gordon, 2003; Krieger, 1990; Moormeier, 1996). Even after these factors have been taken into 
consideration, racial and geospatial disparities still exist. It is important to explore how these 
individual and social factors are associated with breast cancer diagnosis, broken down by 
subtype. 
Gaps in the literature and this study’s contributions 
Research has primarily been focused on identifying individual risk factors with small 
sample sizes. There appears to be a consensus that age and race play significant roles in the 
diagnosis of TNBC, yet with the knowledge we have, disparities still persist. This dissertation 
aims to validate these small study findings, as it is the first to use a near complete population 
dataset, the United States Cancer Statistics database (USCS). It takes a step back and evaluates 
how the social environment may play some role in TNBC diagnosis. Additionally, it allows us to 
evaluate modifiable risk factors in TNBC, thus is more useful in addressing the disparities 
between Non-Hispanic black and Non-Hispanic white women. When analyses are done at the 
local geopolitical level, such as the county, we are able draw conclusions and in turn develop and 
implement prevention strategies that are more conducive to these well-defined geographic areas. 
With the recent, wider availability of the USCS database, more studies are beginning to 
examine societal and community contributors to breast cancer diagnoses.  Some of these have 
used a spatial analytic perspective (Kuo et al., 2011; Mobley et al., 2017; Mobley & Kuo, 2015a, 
2015b; Mobley, Kuo, & Andrews, 2008; Mobley, Kuo, Urato, et al., 2012; Mobley, Kuo, 
Watson, et al., 2012; Mobley, Scott, Rutherford, & Kuo; Mobley et al., 2017).  The few studies 
that have examined community characteristics have been mainly descriptive (Beyer & Rushton, 
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2009; Roche, Skinner, & Weinstein, 2002). Race and residential segregation as representatives 
for social support has been of particular focus when examining breast cancer disparities (Bradley 
et al., 2002; Haas et al., 2008a, 2008b; Kuo et al., 2011; Mobley et al., 2017; Warner & Gomez, 
2010). The use of the expansive Spatial Impact Factor (SIF) dataset along with other free, public-
use population health data allows for more in depth identification and evaluation of additional 
potential contributors.  The SIF database contains a time series of cross sections reflecting 
multiple community level variables including but not limited to residential segregation, poverty, 
income inequality, food security and urbanicity.  The database is supplemented by additional 
data from the Area Health Resource File and Pennsylvania State University (Bureau of Health 
Workforce, 2017; Rupasingha, Goetz, & Freshwater, 2006). These data are drawn primarily from 
the U.S. Census Bureau data. 
Few descriptive studies have explored individual and community (county and state) level 
contributors to breast cancer outcomes, using multilevel analysis or spatial regression. This study 
will update previous SEER registry publications by expanding the geographic scope of these 
studies. The use of the comprehensive USCS database allows for an unprecedented exploration 
of this health outcome. Additionally, this study will employ statistical methods that allow for 
inference to accompany the more descriptive studies. Geospatial analysis and statistical and 
spatial modeling will provide insight to better inform policy and design prevention strategies, 
particularly due to the inclusion of social environmental risk factors.   
Few previous studies have examined social environmental predictors in triple-negative 
breast cancer.  Using the entire USCS registry database would provide enough of these rare 
cancer cases and a broad spectrum of geospatial heterogeneity, yielding the best possible study 
design for these disparities. Only recently have USCS database studies been conducted 
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concerning population cancer outcomes associated with state-level health policy factors (Mobley 
& Kuo, 2015a, 2015b). Previous studies have also found that constructs representative of social 
support can be influential on both breast cancer screening and stage of diagnosis models (Kuo, 
Mobley, & Anselin, 2011; Mobley, Kuo, Scott, Rutherford, & Bose, 2017; Mobley, Kuo, Urato, 
et al., 2012; Mobley, Kuo, Watson, & Gordon Brown, 2012). These studies provide limited 
evidence that the environment does impact cancer stage at diagnosis. The use of the USCS 
dataset (U.S. Cancer Statistics Working Group, 2017) allows for an expansion of these studies to 
fully inform healthcare policy and may potentially reveal contributory factors to typology and 
staging at diagnosis. 
Methodological Approaches 
This study utilizes a variety of methodological approaches with a comprehensive dataset 
to address the different aspects of TNBC incidence. The USCS dataset provides the best source 
of information on population-based cancer incidence for the nation (Henley et al, 2010). Data 
must meet six USCS publication criteria: 1) case ascertainment is ≥90% complete, 2) ≤5% of 
cases are ascertained solely on the basis of a death certificate, 3) ≤3% of cases are missing 
information on sex, 4) ≤3% of cases are missing information on age, 5) ≤5% of cases are missing 
information on race, and 6) ≥97% of the registry's records passed a set of single-field and inter-
field computerized edits that test the validity and logic of data components (Henley et al, 2010). 
These registries cover approximately 99% of the U.S. population, including 96% of the U.S. 
non-Hispanic white population, 99% of the U.S. non-Hispanic black population, 89% of the U.S. 
AI/AN population, 98% of the U.S. API population, and 96% of the U.S. Hispanic population 
(Henley et al., 2010; U.S. Cancer Statistics Working Group, 2017). This is substantially more 
comprehensive compared to the SEER Program with covers approximately 28 percent of the 
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U.S. population, including 25 percent of non-Hispanic whites, 26 percent of African Americans, 
38 percent of Hispanics, 44 percent of American Indians and Alaska Natives, 50 percent of 
Asians, and 67 percent of Hawaiian/Pacific Islanders (SEER, 2018). 
The first study aims to validate the findings of smaller, more localized studies. 
Traditional epidemiologic analysis is used in this study, such as descriptive statistics, basic 
inferential statistics and logistic regression. Using only the individual level data, we can 
determine the odds of diagnosis with TNBC based on race, age and stage of diagnosis for women 
with breast cancer. This is the first study of its kind to use national data in the exploration of 
differences in person-level factors. However, the use of these methods can often confound race 
and place. 
The second study aims to supplement the descriptive analysis by evaluating descriptive 
geospatial patterns of disease at the county-level. Spatial analysis is the primary methodological 
toolkit used in the proposed study. A variety of geographic information system and spatial 
analytic approaches have been utilized in previous analyses in the literature. These methods often 
include simple GIS and mapping, Bayesian image analysis, SaTScan, and generalized linear 
modeling (Goovaerts, 2010; Gumpertz, Pickle, Miller, & Bell, 2006; MacKinnon et al., 2007; 
McElroy, Remington, Gangnon, Hariharan, & Andersen, 2006). This study will employ the use 
exploratory and confirmatory spatial data analysis through descriptive mapping, the Local 
Moran’s I or LISA statistic and spatial regression. This study focuses on underlying county-level 
factors and how they vary across extremes in the pattern and is limited to ecological 
interpretation due to the use of contextual data. The use of geospatial analysis allows us to 
pinpoint where problems and disparities exist, thus we can better develop prevention programs as 
well as provide informed, culturally competent treatment.  There is great potential to reveal new 
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information or confirm existing information on disparities within this outcome due to the various 
spatial analytic methodologies and datasets proposed for this study. 
The third study moves further into explaining how person-, county- and state-level 
factors can explain TNBC diagnosis at the individual level. To address the fallacies of single-
level research, it is important to consider contexts and multi-level phenomena when conducting 
population health research (Oakes, 2009). Additionally, the multi-level approach allows us to 
address spatial heterogeneity found in the previous studies from this dissertation, and causality 
cannot be inferred from this study. Rather, this study aims to inform the literature on potential 
contextual contributors to disparate rates and explore if disparities persist when controlled for. 
The socioecological model acknowledges the importance of context and this study aims to 
elucidate the specific role residential segregation and socioeconomic conditions play in diagnosis 
(Gomez et al, 2015). Multi-level studies can be used to inform multi-level interventions. We 
consider the socioecological model of the cancer continuum in this study (Figure 1). 
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Figure 1. Socioecological model on the Cancer Continuum (Gomez et al., 2015) 
 
Overall, the proposed study intends to fill several significant gaps in the literature by 
conducting population-based secondary analyses that will evaluate racial, ethnic and geospatial 
disparities in triple negative breast cancer. Current evidence provides reasons regarding why 
research must shift focus from treatment to prevention through the identification of risk factors, 
albeit environmental or genetic, that exacerbate disparities in breast cancer diagnosis to create 
and implement more efficacious population-based prevention strategies. The study will use data 
from United States Cancer Statistics (USCS) database, which includes combined cancer 
incidence data from the Center for Disease Control and Prevention’s (CDC) National Program of 
Cancer Registries (NPCR) and the SEER Program. Each data point in the study is considered a 
case and we expect over 1 million observations in the time period of 2010 to 2014. Case-only 
studies are useful in understanding the heterogeneity among the cases (Begg & Zhang, 1994; 
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Trivers et al., 2009). This data covers 99% of the population during 2009-2013 and 92% during 
1999-2013 (Richardson, Henley, Miller, Massetti, & Thomas, 2016).  
No previous studies have examined disparities and their predictors in triple-negative 
breast cancer or other aggressive, invasive cancer typologies using the entire USCS database. 
Both demographic and geographic disparities exist, and these are different constructs that must 
both be elucidated to inform disparities reduction descriptive analysis is the first national 
analysis of population-based cancer incidence.  
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Statement of Purpose 
The purpose of this study is to evaluate racial and geographic disparities in triple-
negative breast cancer (TNBC) diagnoses by race or ethnicity both within regions and across 
regions. The primary outcome of interest is TNBC, breast cancer with immuno-histochemical 
suppression of estrogen-receptor (ER), progesterone receptor (PR), and human epidermal growth 
factor receptor 2 (HER2), at first diagnosis.  Previous studies have examined disparities but not 
on the population scale, often focusing on the individual level. Studies also fail to examine multi-
level effects, which is what this study will examine. This study will evaluate spatial clustering of 
TNBC at the county-level and examine environmental predictors of triple-negative breast cancer 
status using NPCR data available for 45 states, combined with SEER data for the remaining 5 
states. This study uses a subset of the data to include states that allow the use of county-level 
incidence data, have available contextual data, as well as states that code for TNBC. This reduces 
the state sample size to 39 states. Five states do not provide county-level breast cancer data – 
Illinois, Kansas, Michigan, Minnesota and Missouri – and four do not code for triple negative 
data – Connecticut, Iowa, New Mexico, and Utah. Alaska and Hawaii are excluded from analysis 
due to missing contextual data. This study aims to account for personal, social and environmental 
factors such as age, race, socioeconomic status, residential segregation and other neighborhood 
characteristics and their impacts on TNBC outcomes.  
The overarching goal of this study is to advance the field of population-based research in 
breast cancer disparities through innovative statistical techniques. The objective of this study is 
to address racial and geospatial disparities in triple-negative breast cancer diagnosis and to 
examine potential predictors of diagnosis. Breast cancer, in general, carries an enormous public 
health burden and triple-negative breast cancer accounts for 15% of all breast cancer diagnoses. 
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Morbidity and mortality burdens are higher with this type of breast cancer and diagnosis has 
been significantly associated with younger age, African American race, later stage diagnosis, 
lower socioeconomic status and shortened survival. The proposed study will be the first of its 
kind to use data from the United States Cancer Statistics database which includes combined 
cancer incidence data from the Center for Disease Control and Prevention’s (CDC) National 
Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results 
(SEER) Program covering 99% of the population in comparison to 28% with SEER data alone. 
This study will focus on racial disparities between Non-Hispanic black and Non-Hispanic white 
women and geospatial disparities across the contiguous United States. It will evaluate individual, 
social and physical environmental factors that contribute to disparate rates of diagnosis and 
survival. Predictors of interest include, but are not limited to, person level-predictors – race, age, 
and stage of diagnosis, county-level predictors – residential segregation, social capital and 
socioeconomic climate, and state-level predictors – breast cancer screening rates, state-specific 
restrictions on Nurse Practitioner or Physician Assistant scope of practice, and underinsurance or 
self-insurance policies. Descriptive epidemiologic analysis will allow us to compare incidence of 
triple negative breast cancer across race and age groups at multiple geographic levels. 
Exploratory and confirmatory spatial data analysis will be used to create descriptive maps and 
evaluate patterns of geospatial clustering and underlying community characteristics. Multilevel 
modeling with latent variables will allow us to explore predictors of triple-negative breast cancer 
diagnosis and survival. Results will robustly answer the question of both ‘why?’ and ‘where?’ 
thus potentially informing policy at actionable geographic levels and adding valuable 
information to cancer health disparities research as a whole.  
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We expect to find evidence of racial and geospatial disparities in TNBC. Additionally, 
we expect statistical evidence of positive spatial autocorrelation of TNBC rates and that clusters 
will have distinct community characteristics. Finally, we expect that the use of multi-level and 
spatial analytic methods will better elucidate the various predictors and pathways of TNBC 
outcomes and perhaps reveal specific geographic areas in greatest need of prevention or 
intervention. The usual challenge in tackling this type of analysis is data limitation; however, we 
largely overcome that by using the USCS database which covers 99% of the cancer population. 
Identifying information will be protected due to the secure nature of the Research Data Center 
and work conducted there, and the de-identification of datasets. Future work will expand upon 
this spatial analytic research foundation to examine other types of breast or other cancers 
demonstrate disparate rates, such as colorectal, cervical and prostate cancer. 
The use of spatial analysis in a variety of methodologies allows us to robustly answer the 
questions of ‘Why?’ and ‘Where?’ these cancer diagnoses are occurring. State and county level 
characteristics will be used to model the spatial heterogeneity of TNBC diagnoses. Mixed 
modeling allows us to examine multi-level variable predictors and influence on this particular 
type of cancer diagnoses.  There is no literature comparable and the proposed study will help fill 
several significant gaps in the literature.  This data-intensive, information-rich research strategy 
is the future of applied population health research. 
Study 1. Descriptive Analysis of Black/White Disparities in Triple Negative Breast Cancer for 
the US – A Population Based Study from the USCS database 
Triple negative breast cancer (TNBC) accounts for approximately 15% of all breast 
cancer cases, and is associated with aggressive histology, poorer prognosis, shorter survival, and 
unresponsiveness to usual hormone therapy (Bauer et al., 2007). A study conducted using the 
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California cancer registry found that the triple negative phenotype was statistically significantly 
associated with younger age, African American race/ethnicity, later stage diagnosis, lower SES 
and shortened survival (Field et al., 2012; Field et al., 2005). Non-Hispanic black women also 
have a significantly earlier age at diagnosis, high grade tumors, and a higher proportion of triple-
negative breast cancers (Chu et al., 2003; Newman, 2005). The focus on TNBC is crucial as 
there is a lack of therapeutic options for this specific typology. Thus, if one group is 
disproportionately affected, the results can be devastating. No studies have examined racial 
disparities across the US with the USCS database, as few have looked beyond the scope of one 
state. 
The research questions of interest are: Are the underlying distributions of age, race and 
stage at diagnosis different for women with TNBC compared to women with all other types of 
breast cancer? Do the odds of TNBC diagnosis among women with breast cancer differ by race, 
age or stage at diagnosis, at the individual level? The research hypotheses are as follows: Non-
Hispanic black women will have higher odds of TNBC diagnosis than their non-Hispanic white 
counterparts in nationally aggregated data analysis. Younger women will have higher odds of 
TNBC diagnosis and those diagnosed at late stage will have higher odds of TNBC diagnosis. 
A descriptive epidemiologic study of the population dataset will be conducted to 
determine whether there are non-Hispanic black-non-Hispanic white disparities between cases 
with BC, and subcases with TNBC diagnoses. The unit of analysis is the individual. Proportions 
and confidence intervals will be calculated and tested, using Chi-Square tests of independence to 
detect differences in distributions of age groups and race. T tests will be used to detect 
differences in average age.  Bivariate and multivariate logistic regression analyses will be 
performed to calculate odds ratios and confidence intervals comparing non-Hispanic black and 
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non-Hispanic white differences, age group differences, and stage differences in diagnosis across 
states of triple-negative diagnosis among breast cancer cases.  This approach is similar to the 
Bauer and colleagues (2007) California registry study. 
Study 2. Examination of Geospatial Patterns in Triple-Negative Breast Cancer and Factors 
across the United States 
Geographic disparities in breast cancer and its late-stage diagnosis have been established 
in the literature for several years (Henley, King, German, Richardson, & Plescia, 2010; Kerner, 
Andrews, Zauber, & Struening, 1988; Siegel et al., 2018) Kerner and colleagues (1988) called 
for the use of spatial analysis to inform prevention strategy and policy implementation. Since 
then, a few studies have utilized spatial analysis in the evaluation of breast cancer outcomes 
overall, and none have evaluated the TNBC typology (Sheehan et al., 2004; Wang, McLafferty, 
Escamilla, & Luo, 2008; Wang, Burau, Fang, Wang, & Du, 2008). Additionally, no such studies 
focused on the United States have utilized Anselin’s Local Moran’s I (LISA) statistics in the 
analysis (Anselin, 1995). While other methods look for epicenters in a global pattern, the LISA 
methodology accounts for local spatial instabilities in overall patterns of global spatial 
association. This methodology is considered more reliable for inference in both the absence and 
presence of spatial autocorrelation, allowing for the identification of concentrations of both high 
and low values, and spatial outliers. Examining the spatial distribution of this aggressive triple-
negative subtype at the county level provides insight at policy-actionable geographic levels. Use 
of the comprehensive USCS database provides population-based results that are completely 
generalizable. The proposed study seeks to fill several methodological and data-based gaps in the 
literature. 
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The research questions are as follows: Is there evidence of geospatial disparities in both 
breast cancer and triple negative breast cancer diagnosis across the United States? Do these 
clusters coincide? Can residential segregation and socioeconomic conditions predict triple-
negative diagnosis? The research hypotheses are: There will be evidence of observed spatial 
patterns (clustering) of higher-than-average and lower-than-average TNBC rates across the 
United States. TNBC county rates will be associated with indicators of community disadvantage. 
Presuming the presence of spatial clusters will lead to efforts to determine socio-ecological and 
environmental characteristics associated with observed spatial patterns (e.g. socioeconomic 
conditions and residential segregation).  
Descriptive maps will be generated to demonstrate the distribution of TNBC across the 
United States. The unit of analysis is the county. Spatial clustering is expected when examining 
geospatial disparities. The first step is to determine the degree of global clustering using the 
Global Moran’s I statistic. The null hypothesis states that the attribute (i.e., TNBC rates) is 
randomly distributed among features (i.e., counties) in the study area – the contiguous United 
States.  The larger the Moran’s I statistic, the greater the local area variation observed in the 
disease rates.  A rejection of the hypothesis of spatial randomness with the Moran’s test 
predicates use of the Local-Indicators of Spatial Analysis (LISA) test for identification of local 
clusters. Positive spatial autocorrelation in TNBC rates among counties is represented by both 
high-high and low-low clusters, while negative spatial autocorrelation is represented by high-low 
and low-high clusters  
Community characteristics will be represented using data from the Spatial Impact Factor 
Database. The database is supplemented by additional data from the Area Health Resource File 
and Pennsylvania State University (Bureau of Health Workforce, 2017; Rupasingha, Goetz, & 
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Freshwater, 2006). This portion of the study will examine how one’s social environment may 
correlate with rates of breast and triple negative breast cancer.  Spatial regression techniques will 
be employed to evaluate the association between county level social environment factors and 
aggregate triple negative breast cancer rates. 
Study 3. Multi-level Analysis of Person-, County- and State-Level Contributors to Triple-
Negative Breast Cancer Diagnosis among Women in the United States 
The use of the mixed models is a novel approach to ecological-type regressions that 
investigate risk factors (e.g. socioeconomic conditions, residential segregation, social capital, 
housing adequacy from a health standpoint, access to primary care healthcare providers, and 
state insurance mandates) related to breast cancer outcomes (Liu, Wall, & Hodges, 2005). This 
could provide greater insights and explain substantially more of the variation in the observed 
outcome. Multilevel modeling will be employed to explain the variation in TNBC diagnosis at 
the individual level using person, county and state level predictors (e.g. socioeconomic 
conditions, residential segregation, access to primary care healthcare providers, and state 
insurance mandates). The aggregate level variables will include the community characteristics 
such as socioeconomic conditions, residential segregation and social capital, and state-level 
characteristics such as breast cancer screening mandates, and implementation of 
Medicare/Medicaid expansion or state-specific restrictions on Nurse Practitioner or Physician 
Assistant scope of practice. With this enhanced knowledge and effective dissemination and 
translation of it, policies and interventions can be designed and targeted to address the barriers 
and gaps that contribute to the observed TNBC outcomes.  Model building for multilevel 
analysis will allow us to explore how these predictors contribute to diagnosis of TNBC among 
BC patients. 
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The research questions are as follows: What is the predicted probability of triple negative 
breast cancer diagnosis, given breast cancer diagnosis, among females in an average county in 
the United States? What community variables are strong predictors of triple negative breast 
cancer diagnosis among breast cancer cases? When we control for patient, county and state 
characteristics, what is the relationship between patient race and odds of TNBC diagnosis, given 
breast cancer diagnosis? The research hypotheses are: TNBC diagnosis will vary for females 
across counties and counties within states and will be associated with several factors reflecting 
community disadvantage. We anticipate that the odds of triple negative breast cancer diagnosis 
will remain higher for Non-Hispanic black women compared to Non-Hispanic white women, 
even when controlling for county and state level characteristics.  Multilevel analysis will explain 
the variation in diagnosis within and between racial groups using person, county and state level 
predictors. 
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Abstract 
 Triple negative breast cancer has been associated with a more aggressive histology, 
poorer prognosis and nonresponsiveness to hormone therapy. Due to the lack of therapeutic 
options for this cancer type, it is imperative that cancer research identify factors that drive 
disparities and focus on prevention. This study expands upon the literature by examining the 
outcome in population-setting rather than a sample, which can validate previous findings, by 
capturing the majority of the population. Using the United States Cancer Statistics database, we 
identified 1,151,724 cases of breast cancer from 2010-2014, with the triple negative phenotype 
accounting for approximately 8.4% of all cases. The underlying distribution of age, race, and 
stage were statistically significantly different when we compared triple negative breast cancer 
cases to all other breast cancer cases. Unadjusted and adjusted logistic regression results found 
that Non-Hispanic black and Hispanic women had higher odds of diagnosis when compared to 
non-Hispanic white women, with non-Hispanic black women having over twice the odds of 
diagnosis. Additionally, those less than 50 years old had higher odds of diagnosis while those 
over 64 had lower odds, compared to age 50 to 64.  Women younger than 40 had the highest 
odds of diagnosis, as compared to the referent group, with an odds ratio of approximately 1.8.   
Diagnosis at stage III and beyond conferred higher odds of diagnosis of triple-negative breast 
cancer.  In adjusted analyses, these disparities persisted. A subset analysis was conducted on just 
non-Hispanic black and non-Hispanic white cases to explore the interaction of age, race and 
stage. This subset accounted for approximately 86% of the breast cancer population. Adjusted 
logistic regressions were run with age, race and stage as predictors of triple negative breast 
cancer diagnosis. Interaction effects of age and stage by race were explored. Stage and race were 
statistically significant moderators of the relationship between age and diagnoses of triple 
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negative breast cancer. As age increased the odds of triple negative diagnosis decreased, 
however those diagnosed at late stage had higher odds of triple negative breast cancer compared 
to those diagnosed in early stage. Additionally, non-Hispanic black women consistently had 
twice the probability of triple negative diagnosis. This study shows that there is significant 
burden of disease in triple negative breast cancer for women of color, specifically non-Hispanic 
black women, and younger women. Additional studies need to be conducted to determine what 
may be driving these disparities between race, age and stage. 
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Introduction 
Triple negative breast cancer (TNBC) accounts for approximately 15% of all breast 
cancer cases, and is associated with aggressive histology, poorer prognosis, shorter survival, and 
unresponsiveness to usual hormone therapy (Bauer, Brown, Cress, Parise, & Caggiano, 2007). A 
study conducted on a sample of 51,074 women using the California cancer registry found that the 
triple negative phenotype was statistically significantly associated with younger age, African 
American race/ethnicity, later stage diagnosis, lower SES and shortened survival (Field et al., 
2005). This study is one of a few that include personal SES data. Non-Hispanic black women 
also had a significantly earlier age at diagnosis, high grade tumors, and a higher proportion of 
triple-negative breast cancers (Chu, Lamar, & Freeman, 2003; Newman, 2005). Chu and 
colleagues study had a sample size of 107,612. The focus on TNBC is crucial as there is a lack of 
therapeutic options for this specific typology, thus research must shift focus from treatment to 
identifying risk factors, albeit environmental or genetic, that exacerbate disparities in breast 
cancer diagnosis in order to create and implement more efficacious population-based prevention 
strategies. 
Although research has established multiple individual-level risk factors associated with 
general breast cancer diagnoses, racial disparities still exist, particularly between Non-Hispanic 
white and Non-Hispanic black populations. While age-adjusted incidence rates are higher in 
Non-Hispanic white women, mortality rates are higher in Non-Hispanic black women. Age-
adjusted incidence rates from 2011- 2015 were 128.6 per 100,000 for non-Hispanic white 
women and 126.9 per 100,000 for non-Hispanic black women. The age-adjusted mortality rates 
from breast cancer in 2011-2015 for Non-Hispanic black women was 28.7 per 100,000 and 20.3 
deaths per 100,000 for Non-Hispanic white women (Noone et al., 2018). Research indicates that 
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survival in Non-Hispanic black women may be worse due to a higher frequency of adverse 
histologic features (Bauer et al., 2007). When examining cases from 2008 to 2014, Non-Hispanic 
white women had a higher percentage of localized disease when compared to Non-Hispanic 
black women (63% vs 54%), yet the 5-year relative survival rate for Non-Hispanic black women 
was lower in terms of localized (99.1% vs 95.4%), regional (86.4% vs 76.6%), and distant stages 
(28.1% vs.19.7%) (Noone et al., 2018).   
No studies have examined racial disparities in TNBC across the US with the USCS 
database, as few have looked beyond the scope of one state. Previous studies have found that age 
and race confer a higher risk of breast cancer diagnosis (Howlader et al., 2013). Older age and 
has been linked to diagnosis with breast cancer, but this relationship is reversed when we look 
further into triple negative breast cancer (Siegel, Miller, & Jemal, 2018). In terms of triple 
negative diagnosis, this type occurs more frequently in younger women and in non-Hispanic 
black women (Bauer et al., 2007; Dent et al., 2007; Haffty et al., 2006; Harris et al., 2006; Morris 
et al., 2007).  These findings have been limited due to their small sample sizes, the smallest of 
which was 474 cases from a clinical trial (Harris et al., 2006) to the largest of 197,274 cases over 
a 10-year period (Morris et al., 2007), thus they are neither spatially representative or 
generalizable. 
With the use of a population dataset this paper aims to validate previous findings in the 
literature, confirming the proportion of breast cancer cases that are triple negative, and the effect 
of age, race and stage on diagnosis. The research questions of interest are: Are the underlying 
distributions of age, race and stage at diagnosis different for women with TNBC compared to 
women with all other types of breast cancer? Do the odds of TNBC diagnosis among women 
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with breast cancer differ by race, age or stage at diagnosis, at the individual level? Is there a 
difference in odds of diagnosis when we compare late stage to distant stage?  
The research hypotheses are as follows: Non-Hispanic black women will have higher 
odds of TNBC diagnosis than their non-Hispanic white counterparts in nationally aggregated 
data analysis. Younger women will have higher odds of TNBC diagnosis and those diagnosed at 
late and distant stage will have higher odds of TNBC diagnosis.  
Methods 
We examined all breast cancer cases diagnosed during 2010–2014 from the United States 
Cancer Statistics (USCS) database, which is a population-based surveillance system of cancer 
registries with data representing 99% of the U.S. population (Richardson, Henley, Miller, 
Massetti, & Thomas, 2016). Most states participate in the USCS registry data system, but five 
did not provide county-level breast cancer data – Illinois, Kansas, Michigan, Minnesota and 
Missouri – and four did not code for triple negative data – Connecticut, Iowa, New Mexico, and 
Utah. Alaska and Hawaii were excluded from analysis due to missing contextual data. 
The dataset was analyzed using SAS Software (SAS 9.4, SAS Institute Inc., Cary, NC). 
Triple negative cases were identified using site specific factors 1, 2 and 15. Late stage was 
defined as diagnosis at AJCC Stage III and beyond, while distant stage is defined as diagnosis at 
AJCC Stage IV. Age groups were defined as less than 40, 40 – 49, 50 -64, 65 – 74, and 75 and 
older with age 50 -64 serving as the referent group. There were six race/ethnicity categories in 
the study: non-Hispanic white, Hispanic, non-Hispanic black, American Indian/Alaskan Native, 
Asian, and Other, with non-Hispanic white serving as the referent category. Descriptive statistics 
were calculated for age, race and stage variables in the dataset. Chi-Square tests and the student’s 
t-tests were employed to compare differences in the distribution of age, race, and stage in triple 
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negative cases versus all other breast cancer cases. Logistic regression was then used to 
determine the odds of diagnosis of triple negative breast cancer given breast cancer and its 
variation by race, age and stage. Adjusted models were run, and late stage and distant stage were 
included in separate models to reduce confounding effects, as the inclusion of both 
simultaneously may diminish the effect of each variable. This approach is similar to the Bauer 
and colleagues (2007) who conducted the California registry study. A repeated analysis was 
conducted on a subset of cases that only included Non-Hispanic white and Non-Hispanic black 
women. The interaction of age and stage, stratified by race, was evaluated for this subset. 
Results 
 We identified 1,151,724 breast cancer cases from 2010-2014, with a mean case age of 
61.864. Approximately 75% of the cases were non-Hispanic white women, 27.68% were 
diagnosed late stage and approximately 5% were diagnosed at distant stage. In this time period, 
triple negative cases accounted for 8.4 % of all breast cancer cases (Table 1). Results from Chi-
Squared tests demonstrate that there is a statistically significant relationship between the 
distributions of race, age group, late stage, and distant stage and triple negative breast cancer 
diagnosis. The triple negative group had a statistically significant lower mean age, 59.3, 
compared to the other breast cancer group, 62.1 (Table 2). 
 Race, age and late stage were all statistically significant predictors in the unadjusted and 
adjusted logistic regression model (Table 3). In unadjusted models, compared to non-Hispanic 
white women, Non-Hispanic black, Hispanic and American Indian/Alaskan Native women had 
statistically significant higher odds of TNBC diagnosis while Asian and Other women had lower 
odds. Non-Hispanic black women had the highest odds of diagnosis (OR=2.27 (95% CI =2.23, 
2.31)), while other women had the lowest odds of diagnosis (OR=0.71 (95% CI=0.64, 0.77)), 
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compared to Non-Hispanic white women. Out of the age groups, compared to women age 50-64, 
women under the age of 40 had the highest odds of TNBC diagnosis, (OR= 1.95(95% CI=1.90, 
2.01)) while those age 75 and older had the lowest odds of diagnosis of TNBC (OR= 0.75 
(95%CI=0.73, 0.76)). Women diagnosed at late stage were 69% more likely to be diagnosed with 
triple negative breast cancer (OR= 1.69 (95%CI=1.68, 1.72)), and women diagnosed at distant 
stage were 47% more likely to be diagnosed with TNBC (OR= 1.47 (95%CI=1.43, 1.51)).  
 In the adjusted model for late stage, only Hispanic women did not have a difference in 
odds of TNBC diagnosis compared to non-Hispanic white women. Non-Hispanic black women 
had 2.1 times the odds of diagnosis with triple negative breast cancer. The youngest age group 
had the highest odds of TNBC diagnosis, while the oldest had the lowest odds. Women age 40-
49 did not have statistically significantly different odds of diagnosis compared to women age 50-
64. For those diagnosed at late stage, the odds of triple negative diagnosis were 1.58 times the 
odds for those diagnosed earlier than stage three. In the adjusted model for distant stage, the 
results were similar. Women age 40-49 had a slightly higher odds of diagnosis with TNBC, 1.09, 
while the results remained the same for Hispanic women. Those diagnosed at distant stage had 
1.39 times the odds of diagnosis of TNBC. 
 In the subset analysis, race, age and stage were used to predict TNBC diagnosis among 
non-Hispanic black and non-Hispanic white women only. The subset had a size of 973,293 
women. All variables in the adjusted model were statistically significant, including the 
interaction effect (Table 4). When stratified by race, the predicted probability of diagnosis for 
TNBC remained higher for non-Hispanic black women than for non-Hispanic white women 
regardless of stage at diagnosis (Figure 1). When we examine probabilities of diagnosis at late-
stage for non-Hispanic black and non-Hispanic white women, non-Hispanic black women 
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consistently had a higher probability of diagnosis. From age 34.8 (2 SD below the mean) to 88.8 
(2 SD above the mean), the probability of diagnosis with TNBC for non-Hispanic black women 
decreased from 24.4% to 15.4%, while the probability of diagnosis with TNBC for non-Hispanic 
white women decreased from 12.4% to 8.2%. The effect of age on stage is slightly greater for 
non-Hispanic black women when we compare coefficients (-0.013 v -0.01). Since the magnitude 
of the slopes is small, the slope does not appear to drastically change in Figure 1. However, the 
slope for non-Hispanic black women is twice as large (-.006) compared to NHW women (-.003). 
The probability of TNBC diagnosis for Non-Hispanic white women at the mean age (61.8) and 
late stage is 0.10, while for non-Hispanic black women, it is 0.19. The predicted difference in the 
log-odds of diagnosis for non-Hispanic black and non-Hispanic white women is 0.374, on 
average.  
Discussion 
 In the multi-state subset of the breast cancer population, approximately, 8.5% of cases 
were classified as triple negative using site-specific factors. These results find that triple negative 
cases account for fewer breast cancer cases (8.5%) than found in previous studies, with smaller 
samples focused on a single state, that show estimates between 12 and 15% (Bauer et al., 2007; 
Brewster, Chavez-MacGregor, & Brown, 2014; Gretchen, Burke, & Anderson, 2010; Lund et al., 
2008; Parise, Bauer, & Caggiano, 2010; Stark et al., 2010; Trivers et al., 2009). The distribution 
of race was different for the triple-negative cases compared to all other breast cancer cases 
(p<.0001).  Non-Hispanic black women accounted for 10.9% of the other breast cancer cases, but 
21.4% of the triple negative cases, while non-Hispanic white women only accounted for 65.7% 
of triple negative cases. In Bauer and colleagues study (2007), non-Hispanic black women 
accounted 4.4% of other breast cancer cases and 10% of triple negative cases. 
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 In the present study, age group distributions were statistically significantly different 
between other breast cancer and triple negative breast cancer cases (p<.0001). The youngest age 
group, less than 40, accounted for 3.8% of other breast cancer cases, and 7.7% of triple negative 
cases. In the most comparable registry study (Bauer, 2007), this age group accounted for more 
breast (5.7%) and triple negative breast cancer cases (12.2%). The proportion of those diagnosed 
at late-stage and distant stage was statistically significantly higher in the triple negative group 
compared to the other breast cancer cases. Late stage diagnosis occurred in 37.9% of triple 
negative cases, and distant stage diagnosis occurred in 6.6% of triple negative cases. This finding 
is contrary to the Bauer study that found that late stage cases of triple negative breast cancer 
account for approximately 15% of the cases and distant stage accounted for 4%. We found 
evidence of different distributions in age, race and stage at diagnosis compared to previous 
studies. These stark differences demonstrate the importance of national population-based studies. 
 Overall, this descriptive analysis confirms disparities previously found in the literature 
and shows that there are significant burdens among women of color, specifically non-Hispanic 
black women, younger women, and women diagnosed at a later stage when it comes to triple-
negative breast cancer diagnosis. This study found that those burdens are higher among these 
groups than previously estimated, potentially due to the use of a more comprehensive population. 
These differences were confirmed in the logistic regression analyses. In both adjusted and 
unadjusted models, non-Hispanic black women had significantly higher odds of triple negative 
diagnosis compared to non-Hispanic white women. The youngest age group also had 
significantly higher odds of triple negative diagnosis. Women diagnosed at late and distant stage 
had significantly higher odds of triple negative diagnosis. The subset analysis of just non-
Hispanic black and non-Hispanic white women shows that disparities persist between these two 
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groups. In our study, we found that non-Hispanic black women have twice the probability of 
diagnosis with triple negative breast cancer, when controlling for age and stage at diagnosis. The 
effect of age and stage at diagnosis differed by race group. Younger age conferred higher odds of 
diagnosis for both Non-Hispanic black and Non-Hispanic white women, however there is a 
larger gap between the probabilities of diagnosis by stage status for non-Hispanic black women. 
 Given the large sample size and geospatial coverage of the data, these results are 
somewhat different and also more generalizable than previous studies. The database needs to be 
monitored for a shift in policy and data quality that would allow for the addition of states not 
currently included in the analysis. Considering these results, it is important to consider what 
additional factors may influence individual level variations in diagnosis. Further exploration into 
additional individual and environmental characteristics is necessary to identify what may be 
driving these disparities in diagnosis. Due to the aggressive nature of triple-negative breast 
cancer, and lack of therapeutic options, it is important to know which groups confer a higher risk 
to better provide intervention.  
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Tables 
Table 1. Descriptive Statistics of Study Population, n=1151724 
Variable N Percent 
Race 
NHW 862205 74.86 
Hispanic 95507 8.29 
NHB 135389 11.76 
AI/AN 5504 0.48 
Asian 44424 3.86 
Other 8695 0.75 
Age 
Age Groups, mean 1151724 61.84 
<40 47329 4.11 
40-49 179715 15.6 
50-64 433798 37.67 
65-74 275982 23.96 
75+ 214900 18.66 
Late Stage 
Yes 310588 27.68 
No 811633 72.32 
Distant 
Yes 54073 4.82 
No 1068148 95.18 
*Missing 29503 2.6 
TNBC 
Yes 96749 8.4 
No 1054975 91.6 
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Table 2. Differences in Frequencies of Age, Race, and Stage for Other Breast Cancers and 
Triple Negative Breast Cancer 
  Other BC n=1054975 TNBC n=96749 Test for Difference 
Variable N Percent N Percent statistic df p 
Race χ 2=9851.15 5 <.0001 
NHW 798626 75.70 63579 65.72    
Hispanic 87069 8.25 8438 8.72    
NHB 114663 10.87 20726 21.42    
AI/AN 5002 0.47 502 0.52    
Asian 41382 3.92 3042 3.14    
Other 8233 0.78 462 0.48    
Age Groups χ2=5051.62 4 <.0001 
<40 39855 3.78 7474 7.73    
40-49 162650 15.42 17065 17.64    
50-64 395805 37.52 37993 39.27    
65-74 256176 24.28 19806 20.47    
75+ 200489 19.00 14411 14.90    
Mean Age*  62.07  59.28 t=59.86 113867 <.0001 
Late Stage χ 2=7182.29 2 <.0001 
Yes 273929 25.97 36659 37.89    
No 752341 71.31 59292 61.28    
Distant χ 2=2311.43 2 <.0001 
Yes 47661 4.52 6412 6.63    
No 978609 92.76 89539 92.55    
Missing** 28705 2.72 798 0.82    
*Satterthwaite T-test used to compare mean age differences (F=1.08, p<.0001 test for equal 
variance). Percent is the mean age for each group.  
**This represents the number of cases that were missing stage data. 
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Table 3. Association between TNBC diagnosis and Race/Ethnicity, Age and Stage at 
Diagnosis 
  Unadjusted Adjusted - Late Stage Adjusted - Distant Stage 
Variable 
Odds 
Ratio 
95% C.I. 
p 
value* 
Odds 
Ratio 
95% C.I. 
p 
value* 
Odds 
Ratio 
95% C.I. 
p 
value* 
Race 
NHW REF   REF   REF   
Hispanic 1.217 1.189, 1.247 0.001 1.106 1.08, 1.134 0.3624 1.13 1.103, 1.158 0.0633 
NHB 2.271 2.233, 2.309 <.0001 2.111 2.075, 2.148 <.0001 2.159 2.122, 2.196 <.0001 
AI/AN 1.261 1.15, 1.382 0.0174 1.188 1.083, 1.305 0.035 1.213 1.105, 1.332 0.014 
Asian 0.923 0.889, 0.959 <.0001 0.851 0.819, 0.885 <.0001 0.847 0.816, 0.88 <.0001 
Other 0.705 0.642, 0.774 <.0001 0.714 0.646, 0.788 <.0001 0.7 0.634, 0.772 <.0001 
Age Groups 
<40 1.954 1.902, 2.007 <.0001 1.759 1.711, 1.808 <.0001 1.886 1.835, 1.939 <.0001 
40-49 1.093 1.072, 1.114 <.0001 1.066 1.046, 1.087 0.1083 1.085 1.065, 1.106 0.0152 
50-64 REF   REF   REF   
65-74 0.805 0.791, 0.82 <.0001 0.848 0.833, 0.864 <.0001 0.832 0.817, 0.847 <.0001 
75+ 0.749 0.734, 0.764 <.0001 0.816 0.8, 0.833 <.0001 0.808 0.792, 0.824 <.0001 
Late Stage 
Yes 1.698 1.675, 1.722 <.0001 1.58 1.558, 1.602 <.0001 -   
No REF   REF      
Distant 
Yes 1.47 1.431, 1.511 <.0001    1.388 1.351, 1.426 <.0001 
No REF      REF   
 
 
Table 4. Adjusted Logistic Regression Results for Non-Hispanic black/Non-Hispanic white 
Subset Analysis, n=973293 
Adjusted Model 
Stratified Results 
Non-Hispanic white, 
n=841450 
Non-Hispanic black, 
n=131843 
Variable Est. S.E. 
p 
value* 
Est. S.E. 
p 
value* 
Est. S.E. 
p 
value* 
Intercept -1.365 0.017 <.0001 -1.785 
 
<.0001 -0.845 
 
<.0001 
NHW REF   -   -   
NHB 0.374 0.004 <.0001       
Age -0.011 0.000 <.0001 -0.010 0.000 <.0001 -0.013 0.987 <.0001 
Stage 0.136 0.017 <.0001 0.139 0.020 <.0001 0.085 1.089 0.013 
Age*Stage 0.002 0.000 <.0001 0.002 0.000 <.0001 0.003 1.003 <.0001 
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Figure 1. Interaction Effects of Stage at Diagnosis on Age at Diagnosis by Race 
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Abstract 
The literature amply demonstrates that disparities exist between age, race and stage of 
diagnosis in triple negative breast cancers, however few studies have addressed how the social 
environment impacts diagnosis. Evaluation of geospatial patterns reflecting disparities is a 
crucial part of cancer research. This ecological study evaluates geographic disparities using 
1,151,724 cases of breast cancer from 2010-2014 in 2430 counties across 39 states. The data are 
aggregated to the county-level using FIPS codes recorded at the time of diagnosis. County-level 
spatial cluster analysis, which is descriptive and spatial regression, which is confirmatory in 
ecological modeling at the county level, were employed to analyze geographic patterns of crude 
breast cancer and triple negative breast cancer rates and their contextual predictors. County level 
contextual factors were drawn from several public-use sources.  
Crude rates were defined as the total number of cases from 2010-2014 per 100,000 
women. Evidence of spatial autocorrelation in both breast and triple negative breast cancer rates 
was found and multiple clusters coincided with one another. The geospatial patterns of crude 
breast cancer and triple negative breast cancer rates were distinct from one another, with most 
high rate clusters for the former in the North and Northeastern United States, and in the South, 
for the latter. We identified where the two types of clusters converged, and 159 counties had both 
high breast and triple negative breast cancer rates, while 97 counties had low breast cancer rates 
but high triple negative breast cancer rates.  In the final spatial error regression model for breast 
cancer rates, all residential segregation and socioeconomic variables were statistically significant 
predictors. In the final spatial lag + error model for triple negative breast cancer, only the 
isolation indices and the diversity index were statistically significant. Both models found that 
residential segregation played a role in the outcomes. Future studies need to account for spatial 
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dependence when looking at geographic data, such as that provided by the USCS database, and 
further explore additional contextual and compositional variables that may contribute to the 
variation in county-level breast cancer rates. 
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Introduction 
Geographic disparities in the diagnosis of breast cancer has been established in the 
literature for several years (Carvalho, Bacchi, Pincerato, Van de Rijn, & Bacchi, 2014; Henley, 
King, German, Richardson, & Plescia, 2010; Kerner, Andrews, Zauber, & Struening, 1988; 
Mobley, Kuo, Scott, Rutherford, & Bose, 2017; Mobley & Kuo, 2015; Scott, Mobley, & 
Il’yasova, 2017; Siegel, Miller, & Jemal, 2018; Tian, Wilson, & Zhan, 2011). Kerner and 
colleagues (1988) called for the use of spatial analysis to inform prevention strategy and policy 
implementation. Since then, a few studies have utilized spatial analysis in the evaluation of 
breast cancer (BC) outcomes overall, and none have evaluated the triple- negative subtype 
(TNBC) (Kuo, Mobley, & Anselin, 2011; Mobley, Kuo, Watson, & Gordon Brown, 2012; 
Sheehan et al., 2004; Wang, McLafferty, Escamilla, & Luo, 2008). Additionally, no such studies 
focused on the United States have utilized Anselin’s Local Moran’s I (LISA) statistics in the 
analysis (Anselin, 1995). While other methods look for epicenters in a global pattern, the LISA 
methodology accounts for local spatial instabilities in overall patterns of global spatial 
association. This methodology is considered more reliable for inference in both the absence and 
presence of spatial autocorrelation, allowing for the identification of concentrations of both high 
and low values, and spatial outliers. Examining the spatial distribution of this aggressive TNBC 
typology at the county level provides insight at policy-actionable geographic levels.  
Besides comparing the geospatial distribution, it is important to examine underlying 
community characteristics. This information can provide insight on the mechanisms by which 
TNBC may be occurring more in certain communities compared to others. Previous studies have 
compared the distribution of community characteristics between high and low cluster centers, 
which is basically a descriptive approach (Mobley, Finkelstein, Khavjou, & Will, 2004; Scott et 
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al., 2017). This study aims to delve further by predicting breast cancer and triple negative breast 
cancer rates through spatial regression techniques covering the entire geography of the sample, 
thereby understanding which variables may have the largest effect on these county level rates. 
This ecological study focuses on the association of residential segregation, education and 
income inequality on triple-negative diagnosis rates in counties. Residential segregation is 
represented by one measure on evenness, the diversity index, and two measures of exposure, the 
isolation indices. The isolation indices used in the study focused on the distribution of the non-
Hispanic black and non-Hispanic white population (Charles, 2003; Massey & Denton, 1988). 
Education data was drawn from the United States Department of Agriculture Rural Atlas which 
derives estimates from the United States Census Bureau’s American Community Survey. This 
variable represented the percent of the population with a four-year college degree or higher. For 
income inequality, the Gini index of income inequality and the poverty rate were used. The Gini 
index represents the income distribution of a county’s residents and is one of the widely used 
measures in the literature on income inequality and health (Chen & Crawford, 2012). A higher 
Gini index implies a higher level of area income inequality (Fan, Wen, & Kowaleski-Jones, 
2016). It is important to include the various dimensions spatial socioeconomic polarization and 
segregation to manage different aspects that might be confounding if omitted, as few studies 
have explored the joint impact of spatial economic and racial polarization on population health 
(Feldman, Waterman, Coull, & Krieger, 2015; Krieger, Singh, & Waterman, 2016). This study is 
driven by ecosocial theory of disease distribution and the hypothesis that women with social and 
economic privilege are most likely to have ER+ tumors (Krieger, Singh, & Waterman, 2016). 
The research questions are as follows: Is there evidence of geospatial disparities in both 
breast cancer and triple negative breast cancer diagnosis across the United States? Do these 
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clusters coincide? Can residential segregation and socioeconomic conditions predict triple-
negative diagnosis? The research hypotheses are: There will be evidence of observed spatial 
patterns (clustering) of higher-than-average and lower-than-average TNBC rates across the 
United States. TNBC county rates will be associated with indicators of community disadvantage. 
Methods 
We examined all breast cancer cases diagnosed during 2010–2014 from the United States 
Cancer Statistics (USCS) database, which is a population-based surveillance system of cancer 
registries with data representing 99% of the U.S. population (Richardson et al, 2016). Most states 
participate in the USCS registry data system, but five did not provide county-level breast cancer 
data – Illinois, Kansas, Michigan, Minnesota and Missouri – and four did not code for triple 
negative data – Connecticut, Iowa, New Mexico, and Utah. Alaska and Hawaii were excluded 
from analysis due to missing contextual data. Community characteristics will be represented 
using data from the Spatial Impact Factor Database (Mobley, 2015). The database is 
supplemented by additional data from the United States Department of Agriculture and 
Pennsylvania State University (Bureau of Health Workforce, 2017; Rupasingha, Goetz, & 
Freshwater, 2006). 
Independent variables included in the study were non-Hispanic black and non-Hispanic 
white isolation indices, Theil’s diversity index, the Gini index of income disparity, poverty, and 
educational attainment. Non-Hispanic black and non-Hispanic white isolation indices are 
measures of exposure that indicate the probability the specified race group will encounter 
another person from their race group within the areal unit (Massey & Denton, 1988). A value of 
1 indicates a perfectly racially isolated county for the respective race. Theil’s Diversity index is a 
multi-group measure that reflects the level of diversity within the county. This county level 
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variable is based on tract-level racial composition. Counties where tracts all have the same 
composition (all individuals in a population are associated with the same racial group) have a 
low diversity index while counties where different races or ethnicities are separated into cultural 
enclaves among the tracts will have high indices (White, 1986). A value of 0 for the diversity 
index indicates no diversity in the population while a value of 1 indicates maximum diversity, 
where individuals are evenly distributed among two or more mutually exclusive groups 
(Roberto, 2015).  
The Gini coefficient is the most commonly used indicator of income inequality, and its 
use here allows for comparisons with other income inequality studies (Farley, 2006; Jones-
Smith, Gordon-Larsen, Siddiqi, & Popkin, 2011). The Gini index reflects the degree to which 
income is equally shared within a county and is one of the widely used measures in the literature 
on income inequality and health (Chen & Crawford, 2012). An index value of 0 represents a 
perfectly equal distribution of income while an index value of 1 represents a perfectly unequal 
distribution of income. Poverty was represented as the proportion of the population in poverty as 
defined by the U.S. Census. Educational attainment was defined as the percent of the population 
age 25 and older with a graduate or professional degree (Evenden, Harper, Brailsford, & 
Harindra, 2006).  
The dataset was combined using the county FIPS code and summary statistics were 
computed using SAS Software (SAS 9.4, SAS Institute Inc., Cary, NC). Triple negative cases 
were identified using site specific factors 1, 2 and 15. Crude BC rates were defined as the total 
number of BC cases from 2010-2014 per 100,000 persons, and crude TNBC rates were defined 
as the total number of TNBC cases from 2010-2014 per 100,000 persons. A shapefile was 
created and following the approach in Mobley et al (2004) and Schieb et al (2013), the Global 
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(Moran’s I) and Local Indicators of Spatial Association (LISA) spatial clustering tests were 
performed using GeoDa software (Anselin, Bera, Florax, & Yoon, 1996; Anselin, Syabri, & 
Kho, 2006). The Queen Contiguity matrix was used for spatial weights. This type of matrix 
defines neighbors as counties that share borders or vertices. Results were mapped in QGIS (free, 
open source GIS software). The global Moran’s I test determines if there is global clustering in 
the pattern of TNBC rates but cannot identify the location of the clusters, thus we use the LISA 
test to identify the local clusters. 
The LISA statistic is computed using conditional permutation, or bootstrapping, that 
holds the value fixed for the county of interest and randomly permutes the remaining values to 
obtain a reference distribution. The observed value is then compared to the distribution to 
determine extremity of the value. Thus, LISA statistics are relative to the observations of the 
variable of interest and clusters are determined significant at the p < 0.05 level. This was 
repeated for each county to 99999 permutations and counties are then classified as either non-
significant or as falling into four categories, relative to the mean (Anselin, 1995). There are four 
types of spatial clusters identified using the LISA statistic: high-high (higher than average rates 
adjacent to higher than average rates), low-low, high-low, low-high. Positive spatial 
autocorrelation (cluster) in BC and TNBC rates among counties is represented by both high-high 
and low-low clusters, while negative spatial autocorrelation (outlier) is represented by high-low 
and low-high clusters (Anselin et al., 1995). Clusters are identified when the observation is more 
similar to its neighbors as summarized by the spatial lag (weighted average of the neighboring 
values) (Anselin, 2004). For spatial clusters, the cores and neighbors are of interest, while for 
spatial outliers, the cores are the actual locations of interest (Anselin, 2004). 
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Descriptive maps were created to assess the distribution of BC and TNBC rates across the 
country (Figures 1 and 2). Additionally, the results of the LISA analyses were mapped. These 
maps show the center of the cluster in color (i.e., red for high-high), while the actual extent of the 
cluster includes the center and its surrounding neighbors as defined by the queen weights matrix 
(Figure 3 and 4). The neighbors are properly included in the cluster, shown here as a grey buffer 
zone around the center. Co-location maps are presented, that demonstrates where BC and TNBC 
clusters and centers occur concurrently and diverge (Figures 5 and 6). Descriptive statistics were 
calculated for the outcome variable, BC and TNBC incidence rates, and the contextual variables 
of interest (Table 1)  
Due to evidence of strong spatial autocorrelation in the spatial cluster analyses, spatial 
regression techniques were employed to estimate the association with county level contextual 
factors and both breast cancer rates and triple negative breast cancer rates from 2010-2014 
(Tables 3 and 4). Independent variables were assessed for multicollinearity prior to inclusion in 
the models. In Geoda, we ran a classic spatial regression – a replication of ordinary least squares 
(OLS) regression with spatial diagnostics, specifically, evaluating the Moran’s I statistic and 
Lagrange Multipliers (LM) for both lag and error utilizing a queen contiguity matrix for both 
breast and triple negative breast cancer rates. OLS must meet certain assumptions: the random 
error terms follow a normal distribution, are independent and have a constant variance. Given the 
Moran’s I results, the assumption of independence is violated by spatial dependence in the data. 
The model specification for OLS (in matrix notation) is as follows: 
𝑦 = X𝛽 + 𝜀            𝜀~𝑁(0, 𝜎2I) 
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where y is the dependent variable with N rows, X is a matrix with observation on K independent 
variables, β is a vector with K regression coefficients, ε is the random error term, σ2 is the error 
variance and I is an identity matrix of dimension N by N (Chasco, 2013). 
In both models, spatial diagnostics show that the Moran’s I of the residuals were 
statistically significant, the errors were not normally distributed and were heteroscedastic. The 
error model was appropriate for the breast cancer model.  For the spatial error model, we utilized 
the General Method of Moments (robust to non-normality) estimation with Kelejian & Prucha 
(KP) Heteroscedastic-consistent errors. This method allows for robust estimation with 
endogenous explanatory variables in the presence of both spatial heteroscedasticity and 
autocorrelation (Table 3) (Chasco, 2013; Kelejian & Prucha, 2010). It outputs the coefficient 
lambda (λ), which is interpreted as a nuisance parameter. The model specifications with a spatial 
autoregressive error term is: 
𝑦 = X𝛽 + u 𝑓𝑜𝑟 u = 𝜆W𝑢 + 𝜀 
where the additional parameters beyond OLS are defined as W𝑢 is the spatial lag of the errors, λ 
is the nuisance parameter and ε is the error with a mean of 0 and variance matrix σ2 (Chasco, 
2013). 
The lag process was appropriate for the triple negative breast cancer model. For the 
spatial lag model, we utilized the General Method of Moments estimation with White variance to 
accommodate the heteroscedasticity (Chasco, 2013; White, 1980). This model outputs the 
coefficient rho (ρ), which is interpreted as a measure of the extent of spatial spillovers. The 
spatial lag model specification with the spatial lagged dependent variable is: 
𝑦 = 𝜌𝑊𝑦 + 𝑋𝛽 + 𝜀 
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where Wy as a N by 1 vector of spatial lags for the dependent variable, ρ is the spatial 
autoregressive coefficient and ε is a N by 1 vector of normally distributed random error terms, 
with mean 0 and homoscedastic variances σ2 (Chasco, 2013). The Anselin-Kelejian test for 
spatial dependence was statistically significant for the lag model on TNBC rates, indicating 
evidence of spatial autocorrelation that was still unaccounted for (Anselin & Kelejian, 1997; 
Anselin & Rey, 1991). We then employed a combined spatial lag and error model using the 
General Method of Moments estimation with KP Heteroscedastic errors (Table 4). The model 
specification for the joint spatial lag and spatial error model is as follow: 
𝑦 = 𝜌𝑊𝑦 + 𝑋𝛽 + 𝑢 𝑓𝑜𝑟 𝑢 = 𝜆𝑊𝑢 + 𝜀 
where the additional parameters beyond OLS are defined as Wy as a N by 1 vector of spatial lags 
for the dependent variable, ρ and λ are the spatial autoregressive coefficients, and ε is the error 
term (Chasco, 2013). The inclusion of Wy allows us to assess the significance of the explanatory 
variables while controlling for spatial dependence. 
Results 
From the participating registries in the USCS database, there were 2430 counties in 39 
states included in the analysis. The average county-level breast cancer rate was 86.1 cases per 
100,000 (SD = 20.9) while the average county-level triple negative breast cancer rates was 7.7 
cases per 100,000 (SD = 4.2). There was a large range of values for each of the outcomes, as 
demonstrated by Figures 1 and 2. Breast cancer incidence rates ranged from 7.1 to 241.0 cases 
per 100,000 while triple negative breast cancer incidence rates ranged from 0 to 30.8 cases per 
100,000. The Moran’s I statistic for both BC (I = 0.29) and TNBC (I = 0.22) rates was positive 
and statistically significant indicating evidence of clustering or positive spatial autocorrelation. 
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There were 231 positive and 264 negative spatial cluster centers found for breast cancer 
rates. There were 107 spatial outliers (Figure 3). There were 175 positive and 226 negative 
spatial cluster centers identified for triple negative breast cancer rates. There were 117 spatial 
outliers (Figure 4). There were 28 cluster centers that coincided for both high BC and high 
TNBC rates and 104 cluster centers for both low BC and TNBC rates. There were 5 centers each 
that diverged, five that were low BC and high TNBC, and five that were high BC and low TNBC 
(Figure 5). When we include the entire clusters, rather than just the centers, there were 159 
counties that were High BC-High TNBC, 324 counties that were Low BC-Low TNBC, 97 
counties that were Low BC-High TNBC and 54 counties that were High BC- Low TNBC 
(Figure 6).  
All contextual variables were statistically significant predictors of breast cancer rates in 
the breast cancer spatial error model. The nuisance parameter, lambda=0.45, reflects the effects 
of omitted county variables that are similar across the county observations. In the spatial lag 
model for triple negative rates, only the isolation variables were statistically significant 
predictors. The spatial autoregressive parameter, rho=0.59, allows us to assess the significance of 
the independent variables after spatial dependence is controlled for. This parameter reflects the 
effects of a weighted sum of the values of the dependent variable at other locations (Anselin & 
Rey, 1991). The significance of the Anselin-Kelejian test indicates that the spatial 
autocorrelation effect is not completely captured by this model. Both spatial parameters were 
statistically significant in the final lag + error model. In this model, all residential segregation 
variables were statistically significant predictors. 
Discussion 
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  This study found distinct geospatial patterns in crude breast cancer and triple negative 
breast cancer incidence rates at the county level. High breast cancer rates were found mainly in 
the northern United States (US), while high triple negative breast cancer rates were found more 
in the southern US. This may be related to the geographic distribution of race across the United 
States. The South and Southeast has the largest concentration of Non-Hispanic black persons 
among all regions in the United States. Given the higher odds of diagnosis among non-Hispanic 
black women, we could expect a spike in crude rates by region, due to distinct demographic 
differences by region. These geospatial patterns were confirmed by the LISA cluster analysis. 
The vast majority of High-High clusters for breast cancer rates were found along the Northern 
region of the eastern seaboard, as well as across the entire northern United States, with a cluster 
in Northeast California and in Central Florida. The majority of New England and Virginia are a 
part of High-High clusters. On the contrary, Texas, Nevada and much of the Southeast and South 
are a part of the Low-Low clusters for this outcome. Out of 2430 counties, 1434 (59.0%) were 
included in a spatial breast cancer cluster. 
 The LISA Cluster map for crude triple negative breast cancer rates showed a distinctly 
different geographic pattern. Results were similar for states like Nevada and Texas, but the 
Eastern part of the United States essentially flips in pattern. Almost no counties from New 
England are located within a cluster, with the exception of a small cluster in eastern New York. 
Virginia, North Carolina, South Carolina, Georgia, Alabama, and Mississippi comprised most of 
the High-High clusters, with a few clusters located in the Dakotas, Idaho, and Montana. There 
were less counties in a spatial cluster for triple negative breast cancer rates, n=1225 (50.4%). It is 
important that future studies explore the dynamics behind spatial outliers, particularly ‘Low-
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High’ counties, to determine mechanisms as to why those counties are faring better than their 
neighbors. 
 Of note, there are 97 counties that have Low BC rates and High TNBC rates (Figure 6). 
These clusters were located on the border of Idaho and Montana, Arkansas, Louisiana, 
Mississippi, Alabama, Georgia, Florida, Virginia, West Virginia, Nebraska and North Dakota. 
As evident by Figures 5 and 6, it is imperative to consider the extent of the full cluster rather than 
just cluster centers. We potentially miss important information by solely focusing on the cluster 
centers. Future studies should examine predictors of county status and evaluate whether there or 
demographic, social, or physical environment differences that distinguish counties in the cluster 
category from other counties.  
In this study, we examined the associations of social environment factors with breast and 
triple negative breast cancer rates. Spatial regression was performed to help assess which factors 
had the largest effect estimates. Two income related variables, the Gini Index and poverty rate, 
had the largest associations with the breast cancer rate. We would expect a perfectly unequal 
county, in regard to the Gini index, to have a 75.6 more BC cases per 100,000 compared to a 
perfectly equal county, on average. Every 10% increase in poverty corresponds to 6.9 cases per 
100,000 decrease in the breast cancer rate, on average. The residential segregation measures for 
isolation had positive associations while the diversity index, a measure of spatial evenness, had a 
negative association on the breast cancer rate. The diversity index measures how evenly racial 
groups are distributed across the county, regardless of the size of each group (Iceland, 2004). The 
higher the value, the more diverse the county. Compared to a perfectly isolated county (where all 
tracts have the same composition), we would expect a county with maximum diversity to have 
28.1 less BC cases per 100,000 on average. A perfectly segregated non-Hispanic black county is 
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associated with a 31.8 increase in BC cases per 100,000 compared to a perfectly integrated 
county, while a perfectly segregated non-Hispanic white county is associated with a 47.5 
increase in BC cases per 100,000, on average. Non-Hispanic white isolation has a larger effect 
on breast cancer rates than non-Hispanic black isolation, but integration (diversity index) 
considering all racial units corresponds with decreased breast cancer rates. Finally, county-level 
higher education had a substantially small effect on the outcome. For every 1% increase in the 
population that has at least a college education, we expect the breast cancer rate to increase by 
0.15, on average. 
Several of these relationships changed for triple negative breast cancer rates. The 
isolation indices and diversity index were the largest and only significant predictors of triple 
negative breast cancer rates and income-related variables were no longer significant. A perfectly 
segregated non-Hispanic Black county is associated with a 4.6 increase in TNBC cases per 
100,000 compared to a perfectly integrated county, while a perfectly segregated non-Hispanic 
White county is associated with a 2.2 increase in TNBC cases per 100,000, on average. The 
diversity index was negatively associated with the outcome. A perfectly diverse county, with 
multiple racial groups distributed among tracts within the county, is expected to have 2.8 less 
TNBC cases per 100,000 than a perfectly isolated county, on average. The average influence of 
county observations by their neighboring observations is represented by rho = 0.634, while the 
nuisance parameter = -0.539.  
When using spatial data, it is important to consider spatial dependencies in analysis. 
Observations are correlated with others that are spatially proximate, violating the assumption of 
independence and resulting in spill-over of information. Failing to account for spatial 
dependencies may obscure effects that are indeed present given the data and can impart 
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misspecification bias. In this case, spatial diagnostics predicate the use of a spatial error model 
for breast cancer rates and a spatial lag + error model for triple-negative breast cancer rates. In 
the breast cancer model, if spatial autocorrelation is ignored, the estimators may be unbiased yet 
inefficient. Consequentially, inference based on the variance would be biased (Anselin & Rey, 
1991). The spatial error model is the correct specification when neighbors react similarly due to a 
common underlying phenomenon. The spatial lag or autoregressive model is the correct 
specification for a diffusion phenomenon among activities of adjacent neighbors. In the triple 
negative model, if spatial autocorrelation is ignored, then the estimators may be biased, along 
with the misspecification issues drawn from a spatial error process.  
Consequently, given the ecological nature of the study, we cannot infer individual level 
behavior from the aggregate rates. Inclusion of individual level variables along with county level 
variables may allow us to account for more variation in the data. Additionally, the use of crude 
rates limits the interpretation of this analysis as crude rates may be a poor measure of underlying 
risk and can spuriously identify outliers in counties with very small populations (Anselin, 
Sridharan, & Gholston, 2007). The literature has also demonstrated that TNBC is associated with 
age. Appropriate population denominators were not available in the dataset to create age-specific 
rates in order to directly adjust the crude rates.  
Overall, this study demonstrates that spatial dependencies exist when we examine both 
outcomes at an aggregate geographic level. To our knowledge, no previous studies have 
examined geospatial clustering of breast and triple negative breast cancer, their co-locations, or 
conducted spatial regression to evaluate context. It is imperative that we continue to explore 
what is causing these spatial processes to better develop prevention and intervention methods. 
Given the ecological nature of the study, it is important to make inferences based around context. 
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Characteristics of the counties that had both low breast and triple negative breast cancer rate 
could inform policy as to what is working to protect the women in these communities. An 
evaluation of differences between those counties and counties where both outcomes are high, or 
breast cancer is low and triple negative is high can further elucidate factors that may be driving 
these geographic disparities. 
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Figure 1. Descriptive Map of 2010-2014 overall breast cancer rates defined by quartile breaks 
 
Figure 2. Descriptive Map of 2010-2014 triple-negative breast cancer rates defined by quartile breaks 
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Figure 3. LISA Cluster Map of 2010-2014 overall breast cancer rates 
 
Figure 4. LISA Cluster Map of 2010-2014 triple-negative breast cancer rates 
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Figure 5. Coincident LISA Clusters Centers 2010-2014 for BC and TNBC rates  
 
Figure 6. Coincident LISA Clusters 2010-2014 for BC and TNBC rates 
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Table 1. Descriptive Statistics for County Level Variables 
Variable Variable Description Mean Std Dev Minimum Maximum 
R_crude_BC Crude breast cancer rate (cases per 100,000 
females) 
86.0783 20.9117 7.080 240.964 
R_crude_TN Crude triple negative breast cancer rate (cases 
per 100,000 females) 
7.7351 4.1726 0 30.769 
Iblack10 Isolation Index: probability that non-Hispanic 
black persons will meet other non-Hispanic 
black persons within defined area, 2010 
0.26251 0.20741 0 0.8647 
Iwhite10 Isolation Index: probability that non-Hispanic 
white persons will meet other non-Hispanic 
white persons within defined area, 2010 
0.73452 0.15163 0.03154 1 
Divr10 Diversity Index (Theil Index): measures the 
even-ness or uneven-ness of the spatial 
distribution of population subgroups in tracts 
within areas (counties), 2010 
0.1981 0.0916 0 0.69685 
G25UP1014 percent of population aged 25+ years with a 
graduate or professional degree, 2010-2014 
29.56426 10.65997 2.63158 75.09149 
GINI_10 GINI index of income disparity, 2010 0.45547 0.0348 0.3321 0.5985 
xpov10 estimated proportion of people of all ages in 
poverty for income year, 2010 
0.14062 0.05214 0.03408 0.53492 
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Table 2. Results of Fitting Multiple Regression Models for Predictors of Breast Cancer Rates (n=2430) 
 Model 1 - OLS in GeoDaSpace 
Model 2 – Spatial Error Model 
(HET) 
 Est. S.E. p value Est. S.E. p value 
Intercept 23.212 6.123 0.000 21.472 6.715 0.001 
Divr10 -23.890 5.330 <.0001 -28.127 7.100 <.0001 
G25UP1014 0.258 0.052 <.0001 0.152 0.064 <.0001 
GINI_10 67.729 14.413 <.0001 75.592 16.511 <.0001 
Iblack10 32.221 2.718 <.0001 31.799 3.425 <.0001 
Iwhite10 45.941 3.002 <.0001 47.541 3.797 <.0001 
xpov10 -68.027 9.023 <.0001 -69.229 10.909 <.0001 
lambda - - - 0.448 0.027 <.0001 
R2 0.1947 - - 0.1922 - - 
Model F-test 97.61 - - - - - 
(df1, df2) (7, 2423) - - - - - 
Spatial Dependence Diagnostics 
 MI/DF Est. p value - - - 
Jarque-Bera Test 2 2195.771 <.0001    
Bruesch-Pagan test 6 55.82 <.0001    
Moran's I (error) 0.223 18.096 <.0001 - - - 
Lagrange Multiplier (lag) 1 296.865 <.0001 - - - 
Robust LM (lag) 1 2.836 0.0922 - - - 
Lagrange Multiplier (error) 1 320.585 <.0001 - - - 
Robust LM (error) 1 26.556 <.0001 - - - 
Est= Parameter Estimate; S.E.= standard error; lambda = Nuisance Parameter; HET = KP 
Heteroscedastic Errors; Multicollinearity Condition Number = 53.816 
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Table 3. Results of Fitting Multiple Regression Models for Predictors of Triple Negative Breast Cancer Rates (n=2430) 
  
Model 1 –  
OLS in GeoDaSpace 
Model 2 - 
Spatial Lag Model 
Model 3 - 
Spatial Lag +Error (HET) 
  Est. S.E. p value Est. S.E. p value Est. S.E. p value 
Intercept 5.066 1.277 <.0001 1.681 1.532 0.273 1.778 1.327 0.180 
Divr10 -5.882 1.112 <.0001 -2.968 1.593 0.062 -2.808 1.340 0.036 
G25UP1014 -0.009 0.011 0.405 -0.017 0.010 0.080 -0.007 0.009 0.395 
GINI_10 -4.645 3.007 0.123 0.355 3.692 0.923 -1.720 3.313 0.604 
Iblack10 9.975 0.567 <.0001 5.189 1.101 <.0001 4.553 1.130 <.0001 
Iwhite10 4.928 0.626 <.0001 2.159 0.865 0.013 2.173 0.780 0.005 
xpov10 0.299 1.882 0.874 -2.954 2.258 0.191 -1.061 1.977 0.592 
rho - - - 0.586 0.113 <.0001 0.634 0.109 <.0001 
lambda - - - - - - -0.539 0.090 <.0001 
R2 0.1196 - - 0.1751 - - 0.1723 - - 
Model F-test 54.85 - - - - - - - - 
(df1, df2) (7, 2423) - - - - - - - - 
Spatial Dependence Diagnostics 
 MI/DF Est. p value MI/DF Est. p value - - - 
Jarque-Bera Test 2 1251.63 <.0001       
Bruesch-Pagan test 6 163.652 <.0001       
Moran's I (error) 0.1214 9.918 <.0001 - - - - - - 
Lagrange Multiplier (lag) 1 108.189 <.0001 - - - - - - 
Robust LM (lag) 1 13.881 0.0002 - - - - - - 
Lagrange Multiplier (error) 1 95.219 <.0001 - - - - - - 
Robust LM (error) 1 0.912 0.3397 - - - - - - 
Anselin-Kelejian Test - - - 1 9.983 .0016 - - - 
Est= Parameter Estimate; S.E.= standard error; rho = Autoregressive Parameter; HET = KP Heteroscedastic Errors; 
Multicollinearity Condition Number = 53.816 
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Abstract 
 While multiple individual level factors have been identified to play a role in the etiology 
of breast cancer and triple negative breast cancer, few studies have used mixed modeling 
techniques to explore the role that additional levels of predictors may play in triple-negative 
breast cancer. Since disparities persist even when known factors are accounted for, the scope of 
research must be expanded to examine factors that contribute to disparate outcomes at an 
ecological level. Mixed modeling can perhaps better account for the spatial heterogeneity in 
these cases. Random intercept mixed models can account for different effects across areas, yet it 
assumes higher levels are independent, thus is limited in terms of handling spatial dependence. In 
this study, we explored the odds of triple negative diagnosis, given breast cancer diagnosis, at the 
individual level controlling for individual, county and state level variables. When controlling for 
county and state level predictors, disparities by age, race and stage persisted. Non-Hispanic black 
women had consistently had twice the odds of diagnosis with TNBC, women age 40 and under 
had 1.7 times the odds of diagnosis and women diagnosed at late stage had 1.5 times the odds of 
diagnosis. County-level residential segregation and educational attainment variables were 
significant predictors of triple negative diagnosis, while no state level policy variables were 
statistically significant predictors, after controlling statistically for random state intercepts which 
account for other omitted state variables. Residential isolation proved to be disadvantageous to 
diagnosis, while residential diversity and area educational attainment were protective. Future 
studies should continue to explore various environmental factors, physical and social, that 
contribute the variation in disparate rates of diagnosis. 
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Introduction 
The use of the mixed models is gaining popularity in studies that investigate area-level 
risk factors (e.g.  socioeconomic conditions, residential segregation, social capital, access to 
primary care healthcare providers, and state insurance mandates) related to individual breast 
cancer outcomes (Gomez et al., 2015). Mixed models can provide greater insights and explain 
substantially more of the variation in the observed TNBC outcomes. Individual risk factors are 
consistently studied and identified, and neighborhood deprivation has been associated with poor 
breast cancer diagnosis, treatment and survival (Downing, Prakash, Gilthorpe, Mikeljevic, & 
Forman, 2007; Akinyemiju et al., 2013; Tannenbaum, Koru-Sengul, Miao, & Byrne, 2013; 
Markossian, Hines, & Bayakly, 2014; Thomson, Hole, Twelves, Brewster, & Black, 2001; 
Sprague et al., 2011). No studies, to our knowledge, have examined multi-level effects, 
specifically of community deprivation, on triple negative breast cancer (TNBC) diagnosis. The 
inclusion of county and state level variables in multilevel modeling can potentially explain 
additional variation in TNBC diagnosis at the individual level. With this enhanced knowledge, 
and effective dissemination and translation of it, policies and interventions can be designed and 
targeted to address the barriers and gaps that contribute to the observed TNBC outcomes.  Model 
building for multilevel analysis will allow us to explore how these various levels of predictors 
contribute to diagnosis of TNBC among BC patients. 
The literature using atomistic modeling of single-level individual data has provided 
several facts.  One study found that having low self-reported education was associated with 
subtypes of estrogen receptor negative and progesterone receptor negative breast cancers 
(Trivers et al., 2009). Additionally, women in their study with triple negative tumors were more 
often of lower self-reported SES. Low socioeconomic status has been linked to decreased rates 
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of screening, greater probability for late-stage diagnosis, receipt on inadequate and disparate 
treatment and higher mortality from breast cancer (Bigby & Holmes, 2005; Gerend & Pai, 2008). 
Regardless of race, poverty is associated with poorer breast cancer outcomes (Gerend & Pai, 
2008). Women who reside in disadvantaged communities may be required to travel longer 
distances with longer wait times to utilize screening and treatment facilities. These factors can 
cause a major hindrance in regular physician visits (Mandelblatt, Andrews, Kao, Wallace, & 
Kerner, 2010; Mandelblatt, Andrews, Kerner, Zauber, & Burnett, 1991; Mandelblatt, Yabroff, & 
Kerner, 1999; Vernon, Vogel, Halabi, & Bondy, 1993).  
Key factors in health care utilization involve accessibility. There is evidence to suggest 
that when nurse practitioners are allowed to practice and prescribe medicine independently, that 
adults utilize the healthcare system more frequently (Kuo, Loresto, Rounds, & Goodwin, 2013; 
Mobley et al., 2017; Stange, 2014). Underinsurance takes into account an insured adult’s 
reported out-of-pocket costs over the course of a year, not including premiums and deductibles.  
A person is defined as someone whose (a) out-of-pocket costs, excluding premiums, over the 
prior 12 months are equal to 10 percent or more of household income; (b) out-of-pocket costs, 
excluding premiums, are equal to 5 percent or more of household income if income is under 200 
percent of the federal poverty level ($22,980 for an individual and $47,100 for a family of four); 
or (c) deductible is 5 percent or more of household income (Collins, Rasmussen, Beutel, & Doty, 
2015). From 2010 to 2014, twenty-three percent of insured adults were underinsured. Uninsured 
and underinsured women are less likely to undergo screening, more likely to receive a late stage 
diagnosis and less likely to survive (Bradley, Given, & Roberts, 2002; Buseman, Byers, Finch, & 
Jacobellis, 2002; Gerend & Pai, 2008; Gordon, Rundall, & Parker, 1998; Hsia et al., 2000; 
Roetzheim et al., 1999). Low-income women have mammography screening rates that are lower 
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than higher income women (Peek & Han, 2004). Additionally, women with lower education 
have lower mammography screening rates (Kerner et al., 2001). 
Few studies have explored the role of social environmental risk factors in triple negative 
breast cancer diagnosis and, of those, most are analyzed at a single level. Chu and colleagues 
found that race or ethnicity had no effect on recurrence or survival among TNBC patients, when 
controlling for ZIP code-based income, but did not use hierarchical techniques (Chu, Henderson, 
Ampil, & Li, 2012). Parise and Caggiano (2017) created an SES index with Census data and did 
not find an increase in odds of TNBC compared to ER-/PR-/HER2+ due to low SES for all 
races/ethnicities using logistic regression. Bauer and colleagues use a similar SES index as above 
in logistic regression and found that TNBC affects younger, non-Hispanic black and Hispanic 
women in areas of low SES (Bauer et al, 2007). 
This paper explores the relationship between age, race and stage at diagnosis and triple-
negative diagnosis among women with breast cancer. As noted in the literature above, disparities 
based on age, race, and stage have been widely published, but additional contributions to the 
literature can be made by exploring and controlling for area-level contextual effects (Howlader et 
al., 2013). In this paper, we include additional social environmental risk factors that may better 
inform both policy and clinical practice. We include area-level factors including residential 
segregation, income inequality, educational attainment and social capital (at the county-level) 
and health insurance rates, mammography screening, and scope of practice regulation policy (at 
the state level). The social environment variables in the socioecological model on the cancer 
continuum drives the theory behind inclusion of variables in this study (Figure 1) (Gomez et al, 
2015). We may still find that there are certain disparities that persist with the addition of these 
variables. The use of multilevel modeling allows you to control for these contextual factors and 
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examine whether the aforementioned person-level relationships remain robust after inclusion of 
additional levels of context. We are also able to examine whether there is any substantial impact 
from area context by looking at the level-2 and level-3 results.  
The research questions are as follows: What is the predicted probability of triple negative 
breast cancer diagnosis, given breast cancer diagnosis, among females in an average county in 
the United States? What community variables are strong predictors of triple negative breast 
cancer diagnosis among breast cancer cases? When we control for patient, county and state 
characteristics, what is the relationship between patient race and odds of TNBC diagnosis, given 
breast cancer diagnosis? The research hypotheses are: TNBC diagnosis will vary for females 
across counties and counties within states and will be associated with several factors reflecting 
community disadvantage. We anticipate that the odds of triple negative breast cancer diagnosis 
will remain higher for Non-Hispanic black women compared to Non-Hispanic white women, 
even when controlling for county and state level characteristics.  Multilevel analysis will explain 
the variation in diagnosis within and between racial groups using person, county and state level 
predictors. 
Methods 
We examined all breast cancer cases diagnosed during 2010–2014 from the United States 
Cancer Statistics (USCS) database, which is a population-based surveillance system of cancer 
registries with data representing 99% of the U.S. population (Richardson et al, 2016). Most states 
participate in the USCS registry data system, but five did not provide county-level breast cancer 
data – Illinois, Kansas, Michigan, Minnesota and Missouri – and four did not code for triple 
negative data – Connecticut, Iowa, New Mexico, and Utah. Alaska and Hawaii were excluded 
from analysis due to missing contextual data and ill-defined counties, leaving 39 states in the 
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analysis. Community characteristics will be represented using data from the Spatial Impact 
Factor Database (Mobley, 2015). The database was supplemented by additional data from the 
Area Health Resource File and Pennsylvania State University (Bureau of Health Workforce, 
2017; Rupasingha, Goetz, & Freshwater, 2006).  
Person-Level Factors 
Late stage was defined as diagnosis at stage 3 and beyond. Age groups were defined as 
less than 40, 40 – 49, 50 -64, 65 – 74, and 75 and older with age 50 -64 serving as the referent 
group. There were six race categories in the study: Non-Hispanic white, Hispanic, Non-Hispanic 
black, American Indian/Alaskan Native, Asian, and Other, with Non-Hispanic white serving as 
the referent category.  
County-level factors 
County level data included in the model were non-Hispanic black and non-Hispanic 
white isolation indices, Theil’s diversity index, Gini index of income disparity, poverty, social 
capital and educational attainment. Non-Hispanic black and non-Hispanic white isolation indices 
are measures of exposure that indicate the probability the specified race group will encounter 
another person from their race group within the areal unit (county) (Massey & Denton, 1988). A 
value of 1 indicates a perfectly racially isolated county for the respective race. Theil’s Diversity 
index is a multi-group measure that reflects the level of diversity within the county. Counties 
where tracts all have the same composition (all individuals in a population are associated with 
the same racial group) have a low diversity index while counties where different races or 
ethnicities are separated into cultural enclaves among the tracts will have high indices (Mobley, 
2015; White, 1986). A value of 0 for the diversity index indicates no diversity in the population 
while a value of 1 indicates maximum diversity, where individuals are evenly distributed among 
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two or more mutually exclusive groups (Roberto, 2015). The Gini coefficient is the most 
commonly used indicator of income inequality, and its use here allows for comparisons with 
other income inequality studies (Farley, 2006; Jones-Smith, Gordon-Larsen, Siddiqi, & Popkin, 
2011). The GINI Index of family income inequality reflects the degree to which income is 
equally distributed between families within a county. A coefficient of 0 represents a perfectly 
equal society where every family has the same income, while a coefficient of 1 represents a 
perfectly unequal society with a great divergence between the richest and poorest families. 
Poverty was represented as the proportion of the population in poverty as defined by the U.S. 
Census. Social capital was a normalized index developed using the number of the following 
establishments in each county: (a) civic organizations; (b) bowling centers; (c) golf clubs; (d) 
fitness centers; (e) sports organizations; (f) religious organizations; (g) political organizations; 
(h) labor organizations; (i) business organizations; and (j) professional organizations, along with 
the percentage of voters in presidential elections, county-level Census response rate, and the 
number of tax-exempt non-profit organizations (Alesina & La Ferrara, 2000; Knack, 2002; 
Rupasingha et al., 2006). Education was further defined from US Census data as the percent of 
the population age 25 and older with a graduate or professional degree (Evenden, Harper, 
Brailsford, & Harindra, 2006).  
State-level factors 
State level variables were nurse practitioner (NP) autonomy laws, percent underinsured, 
and mammography screening rates. Data on NP regulations was provided by the National 
Conference of State Legislatures (NCSL). Underinsurance data are presented as percent of adults 
who were underinsured in 2012 (Collins et al., 2015). Mammography screening rates were 
obtained from the Centers for Disease Control and Prevention Behavioral Risk Factor 
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Surveillance System. These values represent the percent of women age 40 and over who had a 
mammogram in 2010. 
The dataset was combined and summary statistics were computed using SAS Software 
(SAS 9.4, SAS Institute Inc., Cary, NC). Triple-negative diagnosis was coded using site specific 
factors 1, 2 and 15. County and state level data were merged using the FIPS codes. Univariate 
and bivariate relationships were examined in SAS 9.4. Due to the hierarchical structure of the 
data, with cases nested in counties, nested in states, we employed mixed modeling techniques. 
The outcome of interest was triple negative diagnosis (Yes/No) at the individual. In all the mixed 
models, we specified a binary distribution with a logit link. Utilization of the logit response 
function is appropriate when the response probability is small because the logistic distribution 
has greater tail probability than the normal distribution (Gibbons & Hedeker, 1997). Due to the 
size of the dataset and limitations in time, we optimized PROC GLIMMIX to ensure 
convergence in the models. We suppressed the print options and random effects solutions. The 
denominator degrees of freedom method employed was between-within, which utilizes less 
computing resources than the default containment method. Newton-Raphson Ridging option was 
employed with max iterations set to 50, as this option is appropriate in binary distributions 
(Kiernan, Tao, & Gibbs, 2012). Laplacian approximation was not employed in this study due to 
non-convergence of models, rather residual subject-specific pseudo-likelihood was used. This 
does not allow for model comparison using -2 Log Likelihood values and model output did not 
include any other model fit statistics such as the AIC or BIC.  
An intercept-only mixed model, with a test for random intercepts at level 2 and 3, was 
run and the intraclass correlation was calculated (Snijders & Bosker, 2011). The ICC explains 
the percent of the total variance accounted for at various levels. The ICC for state level was 
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 (Raman and Hedeker, 2005). To explore and control for 
contextual county-level effects, we continued to add on to the intercept-only model. Further 
model building included a model with level-1 predictors followed by a model with level-2 
predictors, followed by three separate models, one for each level-3 predictor. We allowed for 
random effects at the county and state level. A small ICC indicated that the variance in the 
observed response stems more from individual differences within groups. However, omitted 
contextual effects could conceivably impart bias on the included person-level effects.  We 
converted the estimates to population case-only odds ratios. We refer to this odds ratio with this 
nomenclature because the population contains only cases on breast cancer, thus it is not a true 
case-control. This population case-only odds ratio approach has been used in cancer studies 
where the authors are examining genes and mutations that lead to cancer (Rosenbaum, 2004). 
Results 
This study included 1,102,113 individuals, 2430 counties, and 39 states. Descriptive 
statistics for the independent variables are presented in Table 1. The intraclass correlation was 
0.008 for states, 0.019 for counties and states, and 0.427 for counties. This indicates that the 
likeness of cases in the same states is 0.81%, the likeness of cases in the same counties in the 
same states is 1.89%, and the likeness of counties in the same states is 42.7%. The individual 
predicted probability of diagnosis in an average county within an average state is 8.7%, derived 
from the log odds of TNBC diagnosis in the intercept only model (Table 2).  
The results of model-building are presented in Table 2. Age, race and stage were 
significant predictors of TNBC diagnosis, given BC diagnosis, in all 6 models. In terms of race, 
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the referent group was non-Hispanic white women in the case only population. Non-Hispanic 
black women had twice the odds of diagnosis even when controlling for county and state level 
covariates. Hispanic and American Indian/Alaskan Native women also had higher odds of 
diagnosis. Asian and Other women had lower odds of diagnosis. Those age less than 40 had the 
highest odds of diagnosis compared to the referent group of 50 -64 years. This age group was 1.7 
times more likely to be diagnosed with TNBC given BC diagnosis. Age 40-49 had slightly 
higher odds, while both age groups above 65 had lower odds of diagnosis. Those diagnosed at 
late stage had 1.6 times the odds of diagnosis with TNBC compared to those diagnosed prior to 
stage III.  
 Isolation indices, the diversity index, and education were statistically significant 
predictors of TNBC diagnosis given BC diagnosis. Compared to a perfectly integrated county, an 
individual in a perfectly segregated county has approximately 1.3 times the predicted odds of 
diagnosis with TNBC in regard to non-Hispanic black isolation, and approximately 1.2 times the 
predicted odds of diagnosis in regard to non-Hispanic white isolation. Compared to a perfectly 
isolated county (where all tracts have the same composition), individuals in a county with 
maximum diversity (multi-group) have approximately 0.7 times the predicted odds of diagnosis 
with TNBC. For every one unit increase in percent of the population that is educated beyond 
college, the predicted odds of diagnosis with TNBC is decreased by 0.9. No state level variables 
were statistically significant predictors of triple negative diagnosis.  
Discussion 
Even with small variance components, it is still imperative to explore social and policy 
factors that may have implications in individual TNBC diagnosis. In an average county and state, 
the individual level predicted probability of TNBC diagnosis was 8.7%, given breast cancer 
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diagnosis. Even when controlling for county and state level factors, non-Hispanic black women 
experienced higher odds of diagnosis of TNBC, followed by Hispanic and American 
Indian/Alaskan Native women. Asian women and Other women had lower odds of diagnosis. 
Younger age and late stage at diagnosis also conferred higher odds of diagnosis.  
At the county level, residential segregation is associated with TNBC diagnosis. Non-
Hispanic black and non-Hispanic white isolation confers higher odds of diagnosis, regardless of 
individual race, controlling for all other factors. However, the diversity index confers lower odds 
of diagnosis. The diversity index is a multi-group measure of spatial evenness that quantifies 
how evenly racial groups are distributed across the tracts within each county. A value of 0 for the 
diversity index indicates no diversity, where all tracts have the same composition, while a value 
of 1 indicates maximum diversity, where all racial or ethnic groups are evenly distributed but 
may be segregated into cultural enclaves among tracts (Roberto, 2015). Thus, diversity within 
the county confers lower odds of diagnosis at the individual level. Residential segregation has 
been a widely studied phenomenon with no consensus on whether it is detrimental or beneficial 
to health. The aim is to determine whether it creates an adverse environment or provides social 
support(Acevedo-Garcia, Lochner, Osypuk, & Subramanian, 2003; Boustan, 2013; Bower et al., 
2015; Charles, 2003; Collins, 1999; Collins & Williams, 1999; Dai, 2010; Dinwiddie, Gaskin, 
Chan, Norrington, & McCleary, 2013; Haas et al., 2008a, 2008b; Hao et al., 2011; Hayanga, 
Zeliadt, & Backhus, 2013; Kershaw, Albrecht, & Carnethon, 2013; Mobley, Kuo, Scott, 
Rutherford, & Bose, 2017; Mobley, Scott, Rutherford, & Kuo, 2016; Williams & Collins, 2001).  
For these particular outcomes, we found that area-level residential segregation, specifically, 
isolation, was detrimental for health, and that diversity within counties provided better outcomes. 
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Area-level higher education conferred lower odds of individual diagnosis while income 
inequality and poverty had non-significant effects.  
No state level variables were significant predictors of individual level TNBC diagnosis. 
However, we expected nurse practitioner laws to have an impact on diagnosis as the literature 
demonstrates improvements in the provision of preventive services to patients when a nurse or 
NP offered screening directly to the patients, bypassing the physician (Beach et al, 2006). There 
is also favorable evidence to support the use of bypassing providers of minority patients to offer 
standardized services (Beach et al, 2006). Another study on Medicare beneficiaries found that 
NPs are also more likely to serve younger populations, females, and minorities, as well as dually 
eligible Medicare and Medicaid. Importantly, they were more likely to practice in primary care 
shortage areas (DesRoches, Gaudet, Perloff, Donelan, Iezzoni & Buerhaus, 2013).  We may not 
have found a significant effect because the variable is analyzed at three levels. Nurse practitioner 
autonomy could potentially increase access for communities most likely to be affected by TNBC 
diagnosis, specifically younger female populations.  Future studies where the variable is 
dichotomized as full autonomy versus reduced or restricted practice may elucidate the role that 
state-level nurse practitioner autonomy plays in individual diagnosis. From 1987 – 2000, 42 
stated adopted screening mandates requiring private insurers within the state to include 
mammography benefits in insurance plans (Bitler and Carpenter, 2011). Given the screening 
mandate, we would expect states to have a higher utilization of mammography screening which 
in turn would affect outcomes. However, there isn’t much literature to show that generous 
insurance coverage will increase screening utilization and millions of Americans still remain un- 
or underinsured (Bitler and Carpenter, 2011).  Overall, we expected access to care, represented 
by the state variables, to lower the odds of diagnosis with TNBC, rather than finding a null 
RACIAL AND GEOSPATIAL DISPARITIES IN TRIPLE NEGATIVE BREAST CANCER 
  89 
effect. However, it is important to note that even with control of these state-level policy 
variables, disparities still existed and individual and county level effects were not attenuated.  
It is important to note that penalized quasi-likelihood estimates of random components in 
generalized mixed models with dichotomous outcomes have previously been found to have a 
downward bias when there are few observations per group (Capanu, Gönen, & Begg, 2013; 
Goldstein & Rasbash, 1996; Raudenbush, Yang, & Yosef, 2000; Rodriguez & Goldman, 1995). 
Given the size of the dataset, we were not concerned with small cell sizes, but acknowledge this 
as a potential source of bias. Future studies should consider the use of a numerical integration 
method such as Laplacian or Adaptive Quadrature. It is important to consider the role the social 
environment plays in individual level diagnosis. Further exploration of macro-level factors is 
necessary to truly evaluate disparities in triple negative diagnosis. Individual level disparities 
were not eliminated with the addition of county and state level variables. We found that even 
when we control for individual age and stage, county residential segregation, education, income 
inequality levels, and state level policy variables, Non-Hispanic black women still had the 
highest odds of TNBC diagnosis compared to non-Hispanic white women, followed by Hispanic 
and AI/AN women. The addition of SES variables at the individual level as well as cross-level 
interactions may provide different insights into what is driving disparities. An exploration of the 
physical context (e.g. environmental contaminants) may elucidate further what may be driving 
the observed TNBC disparities, as well as policy variables. 
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Figure 1. Socioecological model on the Cancer Continuum (Gomez et al., 2015) 
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Table 1. Descriptive Statistics for County and State Level Variables 
Variable Variable Description Mean Std Dev Minimum Maximum 
Iblack10 Isolation Index: probability that non-
Hispanic black persons will meet other 
non-Hispanic black persons within 
defined area, 2010 
0.26251 0.20741 0 0.8647 
Iwhite10 Isolation Index: probability that non-
Hispanic white persons will meet other 
non-Hispanic white persons within 
defined area, 2010 
0.73452 0.15163 0.03154 1 
Divr10 Diversity Index (Theil Index): measures 
the even-ness or uneven-ness of the 
spatial distribution of population 
subgroups in tracts within areas 
(counties). 2010 
0.1981 0.0916 0 0.69685 
G25UP1014 percent of population aged 25+ years 
with a graduate or professional degree, 
2010-2014 
29.56426 10.65997 2.63158 75.09149 
GINI_10 GINI index of income disparity, 2010 0.45547 0.0348 0.3321 0.5985 
sk09 Social capital index created by 
Pennsylvania State University, 2009 
-0.70851 0.83828 -3.92523 17.4405 
xpov10 estimated proportion of people of all 
ages in poverty for income year 2010 
0.14062 0.05214 0.03408 0.53492 
UNDER12 percent of the population that is 
underserved by primary care providers, 
2012 (Kaiser) 
10.37237 5.20211 0.32525 31.50783 
XMAM10 percent of the population that received 
mammograms in 2010 (BRFSS) 
78.57239 3.71165 68.3 87.5 
 
frequencies for Categorical Variables 
  NP2012 = 0 NP2012 = 1 NP2012 = 2  
NP2012 Whether state allowed NPs autonomy 
to diagnose, treat, and prescribe without 
physician oversight. 0: Full autonomy; 
1: Reduced Practice; 2: Restricted 
Practice 
(County) 
1575 
(State) 
18 
(County) 
455 
(State) 
7 
(County) 
400 
(State) 
14 
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Table 2. Mixed Modeling Results for Three-Level Binary Outcome Models to Predict Triple-Negative Diagnosis among Females with Breast Cancer 
 Model 1  Model 2  Model 3  Model 4  Model 5  Model 6  
 Intercept Only Level 1  Level 1 + 2 Level 1 + 2 + NP Law Level 1 + 2 + Under Level 1 + 2 + Mamm 
 Estimate SE OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI 
Level 1 
Intercept -2.3546 0.02789 -2.5285 0.02036     -2.4953 0.1233   
Race             
Non-Hispanic white REF  REF  REF  REF  REF  REF  
Non-Hispanic black   2.068 2.029, 2.107 2.06 2.02, 2.101 2.06 2.02, 2.101 2.06 2.02, 2.101 2.06 2.02, 2.101 
Hispanic   1.186 1.155, 1.218 1.189 1.158, 1.222 1.189 1.158, 1.222 1.189 1.158, 1.222 1.189 1.158, 1.222 
AI/AN   1.116 1.014, 1.229 1.114 1.011, 1.227 1.113 1.011, 1.226 1.114 1.012, 1.227 1.113 1.011, 1.226 
Asian   0.897 0.862, 0.934 0.903 0.868, 0.94 0.903 0.868, 0.94 0.903 0.868, 0.94 0.903 0.868, 0.94 
Other   0.754 0.682, 0.833 0.756 0.684, 0.835 0.756 0.684, 0.835 0.756 0.684, 0.835 0.756 0.684, 0.835 
Age Groups             
50-64 REF  REF  REF  REF  REF  REF  
<40   1.769 1.72, 1.819 1.773 1.724, 1.823 1.773 1.724, 1.823 1.773 1.724, 1.823 1.773 1.724, 1.823 
40-49   1.076 1.055, 1.097 1.078 1.057, 1.099 1.078 1.057, 1.099 1.078 1.057, 1.099 1.078 1.057, 1.099 
65-74   0.845 0.83, 0.861 0.844 0.829, 0.86 0.844 0.829, 0.86 0.844 0.829, 0.86 0.844 0.829, 0.86 
75+   0.819 0.802, 0.836 0.818 0.801, 0.835 0.818 0.801, 0.835 0.818 0.801, 0.835 0.818 0.801, 0.835 
Late Stage             
No REF  REF  REF  REF  REF  REF  
Yes   1.565 1.543, 1.588 1.563 1.54, 1.586 1.563 1.54, 1.586 1.563 1.54, 1.586 1.563 1.54, 1.586 
Level 2 
iblack10     1.256 1.115, 1.415 1.261 1.118, 1.422 1.257 1.115, 1.417 1.257 1.115, 1.416 
iwhite10     1.166 1.013, 1.342 1.16 1.007, 1.336 1.164 1.011, 1.341 1.166 1.012, 1.342 
Divr10     0.679 0.548, 0.842 0.678 0.546, 0.841 0.678 0.547, 0.841 0.68 0.548, 0.843 
G25UP1014     0.994 0.992, 0.996 0.994 0.992, 0.996 0.994 0.992, 0.996 0.994 0.992, 0.996 
GINI_10     0.992 0.56, 1.757 0.981 0.553, 1.739 0.995 0.562, 1.762 0.995 0.562, 1.762 
sk09     0.992 0.975, 1.01 0.993 0.975, 1.01 0.992 0.975, 1.01 0.992 0.975, 1.01 
xpov10     1.161 0.799, 1.687 1.155 0.794, 1.679 1.161 0.799, 1.688 1.155 0.794, 1.68 
Level 3 
NP2012             
0 REF  REF  REF  REF  REF  REF  
1       1.065 0.97, 1.17     
2       1.026 0.946, 1.112    
UNDER12         0.999 0.994, 1.005  
XMAM10            0.999 0.991, 1.007 
Variance Components 
 Estimate SE Estimate SE Estimate SE Estimate SE Estimate SE Estimate SE 
Variance(State) 0.0272 0.0068 0.0126 0.0033 0.0092 0.0024 0.0092 0.0025 0.0095 0.0025 0.0095 0.0025 
Variance(County) 0.0365 0.0026 0.0229 0.0021 0.0173 0.0018 0.0173 0.0018 0.0173 0.0018 0.0173 0.0018 
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 Previous studies in the literature have focused on individual level risk factors, especially 
with the triple negative subtype. The literature found that triple negative cases account for 10% 
to 15% of all breast cancer cases, while this study found that approximately 8% of cases were 
triple negative using site specific factors 1, 2 and 15. Several (13) states were excluded from 
analysis due to lack of either data as a whole or triple negative classification data. Also, the study 
began with 2010 data because prior to that time, registries inconsistently coded TNBC.  There is 
a need for more comprehensive and reliable data collection from registries, in order to truly 
capture each case. These studies in this dissertation found that race, age and stage at diagnosis 
play a significant role, regardless of additional control variables. 
 The three manuscripts presented in this dissertation focused on identifying individual and 
community level factors in triple-negative diagnosis and geographic distribution and disparities 
in breast cancer and triple negative breast cancer rates. The overarching goal of this study was to 
evaluate racial and geographic disparities in triple-negative breast cancer (TNBC) diagnoses by 
race or ethnicity both within regions and across regions and advance the field of population-
based research in breast cancer disparities through innovative statistical techniques. Goals of 
each of the three individual manuscripts were, respectively: (1) to establish the odds of diagnosis 
of triple negative breast cancer among breast cancer cases by age, race, and stage at diagnosis, 
(2) evaluate the geospatial distribution of county-level breast and triple negative breast cancer 
rates and their associations with community level characteristics (socioeconomic conditions and, 
residential segregation), and (3) examine multilevel effects of county and state level variables on 
individual level triple negative diagnosis among breast cancer cases. 
The literature demonstrates that TNBC accounts for 12-15% of all breast cancers, but no 
studies have been conducted at a national level with as rich of data as the USCS. This study 
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identified 96,749 TNBC cases among 1,151,724 BC cases in the United States across 5 years, 
2010 – 2014. The first study aimed to validate previous findings in the literature. No studies have 
been conducted on TNBC at the national level with as comprehensive of a dataset, and this is the 
first of its kind to explore differences in person-level factors at such a large scale. We utilized 
traditional epidemiologic methods to evaluate individual level differences, but these methods can 
confound race and place. The second study built upon the first to describe geospatial patterns in 
the disease at the county-level using exploratory spatial data analysis and examine associations 
with contextual factors using confirmatory spatial data analysis. There are no studies in the 
literature that examine TNBC and BC outcomes and clustering patterns across the United States, 
nor use spatial regression to account for spatial dependence in the outcomes. We know that there 
are both micro- and macro-social processes that can impact health and health outcomes. In the 
third study, we aim to account for multi-level influences on individual TNBC diagnosis, to 
address the fallacies of single-level research.  
The first study found that triple negative breast cancer cases account for fewer breast 
cancer cases than previously described in the literature. This study found that TNBC accounted 
for 8.5% of cases, whereas previous literature estimates that TNBC accounts for 12-15%. The 
study found that, consistent with the literature, in both unadjusted and adjusted analyses, race, 
age and stage were significant predictors of triple negative diagnosis. However, this study found 
that the burdens among women of color, specifically non-Hispanic black and Hispanic women, 
younger women, and women diagnosed at later stage are actually higher than previously 
estimated. We found evidence of different distribution of age, race and stage at diagnosis 
compared to previous studies. Non-Hispanic black and Hispanic women had higher odds of 
triple-negative diagnosis, compared to Non-Hispanic white women. Women under the age of 50 
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had higher odds of triple negative diagnosis while women over 64 had lower odds of diagnosis, 
compared to women age 50 to 64. Diagnosis at stage III and beyond and stage IV and beyond 
also conferred higher odds of diagnosis.   
 The second study found evidence of significant spatial autocorrelation in both breast 
cancer and triple negative breast cancer rates across counties. There were distinct geospatial 
patterns of the crude BC and TNBC rates. The concurrence of breast cancer and triple negative 
breast cancer clusters demonstrated areas of need where both breast cancer and triple negative 
breast cancer incidence rates are higher than average, and where breast cancer rates are lower 
than average while triple negative rates are higher than average. Special attention needs to be 
paid to counties within these clusters. Spatial regression revealed strong effects for residential 
segregation and education, implying that community context may vary across communities along 
with their triple negative diagnosis rates. Additional studies examining other social and physical 
environmental characteristics need to be employed to further elucidate the association between 
environmental factors and triple negative diagnosis. 
 The third study examines spatial heterogeneity in the likelihood of TNBC diagnosis 
through the use of mixed modeling. The significant variance components at the county and state 
level suggest that there is correlation among observations at each of these levels. County-level 
residential segregation and education variables were found to be significant predictors of triple 
negative diagnosis at the individual level.  No state level variables were statistically significant, 
but inclusion of these variables allow for control for state-level policy.  No individual level 
effects were attenuated due to the addition of county and state level effects, indicating that robust 
estimates of disparities exist even with the control of various contextual variables. 
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 Overall, the studies show that disparities exist by age, race and stage even when 
controlling for spatial heterogeneity and dependence.  Controlling for these area-level effects is 
important when population data span the country and geographic disparities are a possible 
confounder.  Several studies have examined whether it is the race or the place that is determining 
disparities, and the importance of including these area context variables in population studies that 
span the country (Gomez et al., 2015).  These three individual level factors - age, race and stage - 
are important to consider in the diagnosis of triple negative breast cancer and targeting of early 
intervention.  
There were several contextual variables that were associated with breast cancer and triple 
negative breast cancer rates. To discover robust disparity estimates at the individual level, it is 
necessary to include them in the model for conceptual reasons.  Further research should be 
conducted to identify other contextual variables of interest that may contribute to variation in 
rates. The addition of compositional effects along with the variables currently included as 
contextual effects may also reveal different results.   As argued by Oakes, to truly know area 
contextual effects, one must hold constant statistically compositional effects that could confound 
the estimates due to selection bias of individuals into communities (Oakes, 2009).  Because the 
focus here was on how omitted context might impact individual-level estimates, we used the 
model specification described here.   
 Given the large sample size and spatial coverage of the data, these results are more 
generalizable than previous studies. Triple-negative data did not become reliable within the 
registries until 2010, and all states still do not include the necessary variables to identify triple 
negative cases. The study is dependent upon and limited by the accuracy of the registry data. 
There is a need for exploration of many other variables that may play a role such as food 
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environment data, since obesity and physical activity have been linked to breast cancer, and 
physical environment data. Research needs to continue to explore what other variables that may 
be driving disparities, including the physical environment. 
 Although the study is the largest of its kind, we were unable to include the full scope of 
the dataset in the analysis due to data sharing restrictions or lack of information on the TNBC 
outcome. Triple negative breast cancer can be identified using three site specific factors, SSF1, 
SSF2, SSF15 equal to ‘020’, and several states did not code appropriately. The study included 39 
states of the 48 available. However, we were still able to identify over 1 million BC cases in the 
5-year span. We found that triple negative cases accounted for far less than previously identified 
in the literature. This may be due to the use of a subset of 39 states. Comparisons of findings 
with the entire SEER registry, as well as annual evaluations of the data, may further validate 
what number may truly represent the prevalence of TNBC cases among BC cases.  In the second 
study, we utilized crude rates due to lack of appropriate population data within the Research Data 
Center to create age-adjusted rates. The geospatial portion of this study needs to be repeated and 
validated using age-adjusted rates. The third study did not find any effects on individual level 
diagnosis for the state level predictors. We expected nurse practitioner autonomy to have an 
impact on diagnosis as the literature demonstrated that NPs often serve low access communities. 
We may not have found an effect because the variable was analyzed at three levels. The mixed 
modeling could be repeated with the NP variable at 2 levels, either comparing full autonomy to 
the remaining two categories or full restriction to the remaining two categories. The social 
capital variable was a normalized variable that was not found to be a significant predictor in any 
of the mixed models. This creates difficulties in interpretation. In a comparison study of social 
capital indices, it was found to be a conceptually valid and robust measure of collective social 
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capital (Lee & Kim, 2013). Future studies could consider manipulation of the variable to a more 
intuitive measure prior to including it in modeling. Additionally, this study used penalized quasi-
likelihood estimates which can have a downward bias in generalized mixed models with 
dichotomous outcomes and small group cells. Given the size of the dataset, this was not a 
concern, but it is acknowledged as a potential source of bias. Future studies should employ 
Laplacian or adaptive quadrature methods. Mixed models account for spatial heterogeneity but 
not spatial dependence. Future studies should employ spatial mixed modeling techniques as the 
capability becomes available. 
 Repeated trend studies from 2010 forward are necessary to track disparities in triple 
negative breast cancer and determine whether improvements towards equity have been made. 
Since the study was employed at multiple levels, it can serve to inform policy at both the local 
and state level. Given the results of this study, there are additional drivers of disparities that are 
currently unaccounted for. Exploration from a theory driven standpoint can further elucidate 
these drivers. It is necessary that researchers consider all possible influences on breast cancer 
disparities and shift focus from the individual to the community. The geospatial analysis showed 
that there exists geospatial disparities. Future studies could examine geospatial disparities for 
race-specific or age-specific rates to determine if these patterns persist when the data are 
stratified. 
 Overall, this study adds to the growing literature of triple negative breast cancer 
disparities. It found that triple negative breast cancer cases accounted for fewer breast cancer 
cases than previously identified in the literature, and that disparities between women based on 
race, age, and stage at diagnosis were more pronounced. It found that Non-Hispanic black 
women consistently had twice the odds of diagnosis with triple negative given breast cancer 
RACIAL AND GEOSPATIAL DISPARITIES IN TRIPLE NEGATIVE BREAST CANCER 
  110 
diagnosis. Women age 40 and under had almost twice the odds of diagnosis and women 
diagnosed at stage III and beyond had 1.5 times the odds of diagnosis. The distributions of age, 
race and stage at diagnosis were distinctly different from what had been previously identified in 
the literature. Additional attention should be paid to other individual level characteristics that 
confer a higher risk of diagnosis. It found that residential segregation plays a role in diagnosis as 
well. In both the spatial regression and mixed model, the latent variables of isolation indices for 
non-Hispanic white and non-Hispanic black persons as well as the diversity index were 
consistently statistically significantly associated with TNBC outcomes at the county and 
individual level.  Residential isolation in non-Hispanic black or non-Hispanic white isolated 
counties were associated with an increase in breast cancer or triple negative breast cancer rates, 
and increased odds of individual diagnosis with triple negative breast cancer. Diversity within 
the counties was associated with a decrease in breast cancer and triple negative breast cancer 
rates, and decreased odds of individual diagnosis. County-level higher education was negatively 
associated with both breast and triple negative breast cancer rates and conferred lower odds of 
triple negative diagnosis. These findings imply there may be additional processes driven by 
residential segregation that promulgate the disparity in diagnosis. It is imperative that cancer 
research continue to explore the micro- and macro-social processes that impact diagnosis with 
TNBC, given its aggressive nature. Treatment development cannot be the only course of action 
when tackling such a heterogeneous disease. This study provides a foundation from which 
additional studies can move forward from, further exploring individual and contextual factors 
that continue to drive disparities in triple negative breast cancer. 
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